phenylalanine has been researched along with Disease Models, Animal in 328 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 77 (23.48) | 18.7374 |
1990's | 30 (9.15) | 18.2507 |
2000's | 89 (27.13) | 29.6817 |
2010's | 105 (32.01) | 24.3611 |
2020's | 27 (8.23) | 2.80 |
Authors | Studies |
---|---|
Avdeef, A; Tam, KY | 1 |
Gu, X; Hong, S; Liang, L; Xu, F; Zhan, X; Zheng, S; Zhu, T | 1 |
Dijkstra, AM; Heiner-Fokkema, MR; Hovens, IB; Huijbregts, SCJ; Kema, IP; Romani, C; van der Goot, E; van der Zee, EA; van Spronsen, FJ; van Vliet, D; van Vliet, N | 1 |
Anarat-Cappillino, G; Bangari, DS; Berthelette, P; Cornell, CS; Gans, J; Geller, S; Hossain, M; Jackson, R; Kyostio-Moore, SRM; Manek, R; Ryan, S; Singh, K; Xu, EY; Yu, D; Zhang, YV | 1 |
Fukuo, Y; Futamura, G; Hiramatsu, R; Hu, N; Kashiwagi, H; Kawabata, S; Miyatake, SI; Suzuki, M; Takata, T; Takeuchi, K; Tanaka, H; Wanibuchi, M; Watanabe, T; Yoshimura, K | 1 |
de Blaauw, P; Heiner-Fokkema, MR; Kema, IP; van der Goot, E; van der Zee, EA; van Faassen, HJR; van Ginkel, WG; van Spronsen, FJ; van Vliet, D | 1 |
Ahring, KK; Brüel, A; Brøndum-Nielsen, K; Christensen, M; Dagnæs-Hansen, F; Jensen, E; Jensen, TG; Johannsen, M; Johansen, KS; Kjolby, M; Lund, AM; Madsen, JG; Møller, LB; Pedersen, M; Sørensen, LK | 1 |
Boutros, S; Dudley, S; Harding, CO; Krenik, D; Raber, J; Rimann, N; Scherer, T; Thöny, B; Winn, SR | 1 |
Ebrahimi, SA; Jafari-Sabet, M; Najafizadeh, P; Rahimi-Moghaddam, P; Sadegipour, A; Torab, M | 1 |
Arthur, RM; Banik, SM; Carl, CS; Contrepois, K; He, Y; Jansen, RS; Kiens, B; Kim, JT; Li, VL; Liu, H; Loh, KY; Long, JZ; Lyu, X; Michael, B; Moeller, BC; Richter, EA; Snyder, MP; Stahl, A; Tanzo, JT; Terrell, SM; Tung, AS; van de Wetering, K; Voldstedlund, CT; Wallis, GA; Wei, W; Wiggenhorn, AL; Xu, Y; Yang, AC; Zushin, PH | 1 |
Chen, YW; Chou, FI; Lee, YJ; Lin, YC; Wang, SY | 1 |
Das, A; Ojha, DK; Reddy, KS; Sahu, W; Suar, M | 1 |
Cho, KM; Jo, JK; Kim, EJ; Kim, HW; Kim, JH; Kwon, SJ; Lee, G; Nguyen, CD; Park, SE; Seo, SH; Son, HS | 1 |
Gao, J; Li, Y; Song, J; Wu, K; Xu, H; Yang, Y; Zhang, Y; Zhao, M; Zheng, Y; Zhou, L | 1 |
Chang, S; Chu, X; Ding, J; Du, C; Feng, T; Ge, C; Geng, M; Gong, Y; Huang, X; Lian, W; Lin, F; Liu, J; Ruan, L; Sun, G; Wang, H; Wang, T; Wang, X; Xiao, S; Xie, Z; Yan, S; Yang, D; Yang, J; Zhang, G; Zhang, H; Zhang, J; Zhang, Q | 1 |
Berguig, GY; Bullens, S; Creer, AY; Martin, NT; Murphy, R; Olbertz, J; Pacheco, G; Weng, HH; Xie, L; Zhang, L | 1 |
Inoue, Y; Kanamori, K; Matsui, M; Nishiyama, N; Nomoto, T; Suzuki, M; Takemoto, H; Tomoda, K; Yao, Y | 1 |
Picklo, MJ; Rust, BM; Yan, L | 1 |
Dudley, S; Fedorov, L; Harding, CO; Richards, DY; Rimann, N; Thöny, B; Winn, SR | 1 |
Benne, JA; Christ, SE; Dobrowolski, SF; Ghaloul-Gonzalez, L; Gollin, SM; Hansen, SA; Johnson, MA; Koppes, EA; Leshinski, A; Lewis, DW; Lichter-Konecki, U; Murphy, SL; Newsome, JT; Nicholls, RD; Prather, RS; Redel, BK; Samuel, MS; Skvorak, KJ; Spate, LD; Vockley, J; Wagner, RA; Walters, EM; Wells, KD; Wu, YL; Yates, ME; Yerle, M | 1 |
Choo, MS; Joung, Y; Jue, M; Kim, JK; Lee, S; Namgoong, JM; Ryu, CM; Shin, DM | 1 |
Burdock, GA; Cowley, AB; Li, QS | 1 |
Blair, HC; Dobrowolski, SF; Goetzman, ES; Phua, YL; Spridik, K; Sudano, C; Tourkova, IL; Vockley, J | 1 |
Lin, IT; Lin, MY; Wang, IJ; Wu, YC | 1 |
Aldabe, R; Allen, KL; Cao, W; Douar, A; González-Aseguinolaza, G; Hillin, LG; Kaiser, RA; Lillegard, JB; Martinez, M; Trigueros-Motos, L; VanLith, CJ; Weber, ND | 1 |
Liu, S; Liu, Z; Pi, Z; Song, F; Wang, A; Zheng, Z | 1 |
Abatan, A; Adnot, S; Breau, M; Bréhat, J; Czibik, G; d'Humières, T; Delmont, T; Derumeaux, G; Halfaoui, M; Hatem, S; Liang, H; Marion, O; Martel, C; Mezdari, Z; Morin, D; Murat Altintas, D; Naushad, S; Pini, M; Radu, C; Sarwar, R; Sawaki, D; Suffee, N; Yavari, A; Zhang, Y | 1 |
Blau, N; Calin, GA; Chatterjee, SS; Coarfa, C; Egranov, SD; Feillet, F; Guéant, JL; Gunaratne, PH; Han, L; Hawke, DH; Hsiao, H; Hu, Q; Hung, MC; Jun, Y; Li, C; Li, Y; Li, YC; Liang, K; Liao, L; Lin, C; Muntau, AC; Namour, F; Nguyen, TK; Pan, Y; Putluri, N; Schiff, M; Sutton, VR; Tan, Z; Tsai, KL; Xing, Z; Xu, J; Yang, L; Ye, Y; Zhang, S; Zhang, Y; Zhang, Z | 1 |
Blair, HC; Dobrowolski, SF; Larrouture, QC; Sudano, CR; Tourkova, IL | 1 |
Agten, SM; Arts, M; Balluff, B; Dubois, LJ; Eijkel, GB; Ellis, SR; Hackeng, TM; Heeren, RMA; Lieuwes, NG; Olde Damink, SWM; Pierzchalski, KA; Soons, Z; van Loon, LJC | 1 |
Cooper, JD; Corado, CR; Goldfinger, M; Laipis, PJ; O'Neill, CA; Tsuruda, LS; Zeile, WL | 1 |
Jayaprakash, P; Kieć-Kononowicz, K; Latacz, G; Nurulain, SM; Oz, M; Sadek, B; Szymańska, E | 1 |
Babiloni, C; Bastlund, JF; Bentivoglio, M; Bertini, G; Bordet, R; Christensen, DZ; Colavito, V; Del Percio, C; Dix, S; Drinkenburg, W; Fabene, PF; Ferri, R; Forloni, G; Frasca, A; Limatola, C; Lopez, S; Noe, FM; Pedersen, JT; Richardson, JC | 1 |
Gershon, MD; Gluck, K; Gross Margolis, K; Israelyan, N; Iuga, A; Li, Z; Saurman, V; Stevanovic, K; Talavera, M; Vittorio, J; Welch, MG | 1 |
Akalestou, E; Alamshah, A; Amarsi, R; Amin, A; Bloom, SR; Cao, Y; Gonzalez-Abuin, N; Gray, GW; Johnson, R; Jomard, A; Kinsey-Jones, JS; Malik, Z; Moolla, A; Murphy, KG; Norton, M; Ramgulam, A; Saleh, K; Sargent, PR; Spreckley, E | 1 |
Abudu, H; Ahemaiti, A; Aximujiang, K; Wu, G; Yunusi, K; Zhang, J | 1 |
Bruinenberg, VM; de Blaauw, P; Heiner-Fokkema, MR; Kema, IP; van der Goot, E; van der Zee, EA; van Faassen, M; van Spronsen, FJ; van Vliet, D | 1 |
Boulton, ME; Corson, TW; Fei, X; Kharwadkar, R; Lee, B; Meroueh, SO; Mitter, SK; Park, B; Qi, X; Seo, SY; Sheik Pran Babu, SP; Si, Y; Sulaiman, RS; Sun, W | 1 |
Harding, CO; Martinez, A; Raber, J; Scherer, T; Thöny, B; Weber, S; Winn, SR; Ying, M | 1 |
Borsch, J; Büttner, L; Danecka, MK; Eichinger, A; Gersting, SW; Möglich, T; Muntau, AC; Woidy, M | 1 |
Bigini, N; Cabib, S; Carducci, C; Colamartino, M; Gabucci, C; Leuzzi, V; Magnani, M; Pascucci, T; Pierigè, F; Puglisi-Allegra, S; Rossi, L; Sasso, V; Valzania, A; Ventura, R; Viscomi, MT | 1 |
Armirotti, A; Caci, E; Cavalli, A; Falchi, F; Ferrera, L; Giacomini, E; Goldoni, L; Mandrup Bertozzi, S; Pedemonte, N; Pesce, E; Ravazzolo, R; Sondo, E; Tomati, V | 1 |
Ito, K; Izui, S; Kakuchi, Y; Kawano, M; Malissen, B; Malissen, M; Mizuguchi, K; Onoe, T; Suzuki, Y; Yamada, K; Yamagishi, M; Zuka, M | 1 |
Kang, S; Kim, CE; Kim, K; Kleinman, HK; Ousler, GW; Sosne, G; Yang, J | 1 |
Belanger, AM; Cheng, SH; Furgerson, M; Gefteas, E; Geller, S; Kloss, A; Przybylska, M; Yew, NS; Zhu, Y | 1 |
Bao, A; Gao, W; Li, Q; Lu, HY; Sun, L; Turvey, SE; Wang, K; Wang, L; Wang, Y; Xiong, Y; Yang, H | 1 |
Seagraves, NJ; Watson, JN | 1 |
Cai, Y; Huang, Y; Jiang, X; Li, D; Li, X; Lin, Y; Liu, H; Liu, L; Liu, Z; Lu, X; Peng, M; Shao, Y; Su, X; Tan, T; Tang, YP; Xu, J; Zeng, C; Zhang, W | 1 |
Cao, J; Chen, S; Liu, W; Luo, X; Qiao, Y; Sun, M; Wen, A; Yang, Z; Zhao, X | 1 |
Abete, P; Aitoro, R; Avagliano, C; Berni Canani, R; Bianco, R; Bonaduce, D; Calignano, A; Ciccarelli, M; Fiordelisi, A; Ghigo, A; Guida, F; Hirsch, E; Iaccarino, G; Li, M; Mercurio, V; Napolitano, F; Paparo, L; Russo, M; Sala, V; Sorriento, D; Tocchetti, CG; Trinchese, G | 1 |
Bruinenberg, VM; Counotte, DS; Kuhn, M; van der Goot, E; van der Zee, EA; van Spronsen, FJ; van Vliet, D | 1 |
Han, XM; Lu, YN; Qin, YJ; Rang, Y; Wang, NX; Zhai, XJ; Zhang, XL; Zhu, Y | 1 |
Bortoluzzi, VT; Brust, L; de Franceschi, ID; Preissler, T; Wannmacher, CMD | 1 |
Grisch-Chan, HM; Harding, CO; Schwank, G; Thöny, B | 1 |
Armstrong, SA; Austin, R; Breyfogle, LJ; Bruedigam, C; Ebert, BL; Heckl, D; Heidel, FH; Hill, GR; Kalaitzidis, D; Kuhn, CP; Lane, SW; Mullally, A; Poveromo, L; Purdon, A; Vu, T; Williams, DA | 1 |
Anderson, KC; Chauhan, D; Lewensohn, R; Munshi, N; Paba-Prada, C; Ray, A; Richardson, P; Spira, J; Viktorsson, K | 1 |
Cayabyab, FS; Gowribai, K; Walz, W | 1 |
Gao, J; Gu, X; He, Y; Liang, L; Lu, L; Zhang, X | 1 |
Andou, A; Dohi, T; Eda, H; Ejima, C; Kageyama, S; Miyazawa, T; Nakayama, A; Sugiura, T | 1 |
du Jardin, KG; Jensen, JB; Pehrson, AL; Sanchez, C | 1 |
de Souza, RA; Mangueira, NM; Pinheiro, AL; Santos, AP; Silveira, L; Villaverde, AB; Xavier, M | 1 |
Arning, E; Bottiglieri, T; Gibson, KM; Vogel, KR; Wasek, BL | 1 |
Bihani, G; Bodhankar, S; Dhaneshwar, S; Kusurkar, M | 1 |
Abraham, S; Anikster, Y; Brenner, O; Harmelin, A; Pode-Shakked, B; Schwartz, G; Shemer-Meiri, L; Stettner, N | 1 |
Budac, D; du Jardin, KG; Jensen, JB; Pehrson, AL; Sanchez, C; Smagin, G; Song, D | 1 |
Bai, Y; Kang, J; Lian, GC; Liu, M; Wang, HL; Wang, HM; Wang, Y; Zhang, XH | 1 |
Corbo, C; Daniele, A; Imperlini, E; Orrù, S; Salvatore, F | 1 |
Chuah, MK; Harbottle, RP; Harding, CO; Schlegel, A; Thöny, B; VandenDriessche, T; Viecelli, HM; Wong, SP | 1 |
Chen, IP; Dutra, EH; Reichenberger, EJ; Tadinada, A; Uribe, F; Utreja, A | 1 |
Morilak, DA; Pehrson, AL; Sánchez, C; Wallace, A | 1 |
Chen, G; Du, Z; Li, B; Li, Y; Sun, T; Wei, Y; Wu, T; Xie, X; Zhou, Y | 1 |
Almand, EA; Mogen, AB; Rice, KC; Richardson, AR; Rivera, FE; Sapp, AM; Shaw, LN | 1 |
Horling, K; Rune, GM; Santer, R; Schlegel, G; Schulz, S; Ullrich, K; Vierk, R | 1 |
Go, YM; Jo, H; Jones, DP; Kang, DW; Kim, CW; Kumar, S; Orr, M; Quyyumi, AA; Uppal, K; Walker, DI | 1 |
Braccini, T; Grandgirard, D; Koedel, U; Leib, SL; Oggioni, MR; Ricci, S; Salvatore, P; Wenzel, M | 1 |
Dirnhofer, S; Duek, A; Grisouard, J; Hao-Shen, H; Kubovcakova, L; Shimizu, T; Skoda, RC | 1 |
Azuma, H; Hirano, H; Ibuki, N; Inamoto, T; Kawabata, S; Kirihata, M; Kiyama, S; Kuroiwa, T; Minami, K; Miyatake, S; Nomi, H; Suzuki, M; Takahara, K; Takai, T; Yoshikawa, Y | 1 |
Galba, J; Kovac, A; Michalicova, A; Novak, M; Parrak, V | 1 |
Corrales, RM; de Paiva, CS; Krauss, AH; Pelegrino, FS; Pflugfelder, SC; Tukler-Henriksson, J | 1 |
Carsten, CG; Chowdhury, A; Gerard, P; Gray, BH; Nahar-Gohad, P; Nosoudi, N; Sinha, A; Vyavahare, NR | 1 |
Contreras-Ruiz, L; Krauss, AH; Masli, S; Mir, FA; Turpie, B | 1 |
Bruinenberg, VM; de Blaauw, P; Heiner-Fokkema, MR; Kema, IP; Mazzola, PN; van Anholt, RD; van der Zee, EA; van Faassen, MH; van Spronsen, FJ; van Vliet, D | 1 |
Harding, CO; Scherer, T; Thöny, B; Winn, SR | 1 |
Biery, A; Dobrowolski, SF; Lyons-Weiler, J; Skvorak, K; Spridik, K; Vockley, J | 1 |
Rune, GM; Santer, R; Schlegel, G; Scholz, R; Ullrich, K | 1 |
Boulton, ME; Corson, TW; Kennedy, B; Lee, B; Merrigan, S; Qi, X; Quigley, J; Seo, SY; Sulaiman, RS | 1 |
Cannizzaro, C; De Caro, V; Giannola, LI; Lavanco, G; Plescia, F; Sutera, FM | 1 |
Morgan, B | 1 |
Ackerman, HC; Alkaitis, MS | 1 |
Bruinenberg, VM; de Blaauw, P; Heiner-Fokkema, MR; Kema, IP; Mazzola, PN; Pascucci, T; Puglisi-Allegra, S; van der Zee, EA; van Faassen, MH; van Spronsen, FJ; van Vliet, D | 1 |
Singh, V | 1 |
Arning, E; Bottiglieri, T; Gibson, KM; Vogel, KR | 1 |
Borzì, RM; Fini, M; Giavaresi, G; Grigolo, B; Maglio, M; Olivotto, E; Politi, L; Scandurra, R; Scotto d'Abusco, A; Veronesi, F | 1 |
Baba, N; Maeda, N; Sagara, Y; Shen, Y; Tsuda, M; Tsuru, E; Wang, F; Yamashita, T | 1 |
Choudhary, AK; Lee, YY | 1 |
Jahan, K; Pillai, KK; Vohora, D | 1 |
Gatchel, JR; Lee, Y; Orr, HT; Samaco, RC; Thaller, C; Zoghbi, HY | 1 |
Cabañero, D; Célérier, E; García-Nogales, P; Maldonado, R; Mata, M; Puig, MM; Roques, BP | 1 |
Rosenberg, GA; Walker, EJ | 2 |
Aromando, RF; Heber, EM; Itoiz, ME; Nigg, DW; Schwint, AE; Trivillin, VA | 1 |
Kawashima, Y; Kudo, N; Shiba, S; Tamura, M | 1 |
Altieri, S; Bakeine, GJ; Bertolotti, A; Bortolussi, S; Bruschi, P; Clerici, A; Di Salvo, M; Ferrari, C; Marchetti, A; Nano, R; Stella, S; Zonta, C | 1 |
Andolina, D; Cabib, S; Conversi, D; Latagliata, C; Mela, IL; Pascucci, T; Puglisi-Allegra, S; Ventura, R | 1 |
Cox, RA; Deyo, DJ; Hawkins, HK; Herndon, DN; Jacob, S; Traber, DL | 1 |
Hashimoto, K; Inoue, T; Iwakura, Y; Izumi-Nakaseko, H; Kakuta, S; Kano, M; Katayama, N; Kiyama, Y; Manabe, T; Murphy, NP; Nakazawa, T; Sudo, K; Taniguchi, S; Tanimura, A; Tezuka, T; Umemori, H; Watabe, AM; Yamamoto, T; Yokoyama, K | 1 |
Choi, JO; Jung, SC; Lee, MH; Park, HY; Park, JW | 1 |
Cao, W; Glushakov, AV; Martynyuk, AE; Mecca, AP; Seubert, CN; Shah, HP; Shi, P; Sumners, C | 1 |
George, SJ; Jackson, CL; Johnson, JL; White, SJ; Williams, H | 1 |
Aigrot, MS; Belachew, S; Bours, V; Hong, P; Josse, C; Lubetzki, C; Marée, R; Schoemans, R; Wu, C | 1 |
Danecka, MK; Domdey, KA; Eichinger, A; Fingerhut, R; Gersting, SW; Glossmann, H; Kemter, KF; Lagler, FB; Messing, DD; Muntau, AC; Roscher, AA; Staudigl, M; Zsifkovits, C | 1 |
Feng, JB; Ge, SL; Gong, WH; Han, PH; Zhang, CX; Zhang, L; Zhang, SQ; Zhou, DC | 1 |
Bhatnagar, S; Kumar, A | 1 |
Danecka, MK; Eichinger, A; Fingerhut, R; Gersting, SW; Glossmann, H; Lagler, FB; Muntau, AC; Staudigl, M; Steinbacher, A; Zsifkovits, C | 1 |
Chen, YZ; Jiang, CL; Jing, ZP; Li, M; Li, Z; Liu, L; Sheng, CQ; Wang, Y; Zhou, J; Zhou, JR | 1 |
Kajioka, T; Kitahara, Y; Miura, K; Takeuchi, M; Yamagishi, S | 1 |
Altieri, S; Bakeine, JG; Ballarini, F; Bortolussi, S; Bruschi, P; Cansolino, L; Clerici, A; Ferrari, C; Gadan, MA; Nano, R; Protti, N; Stella, S; Zonta, A; Zonta, C | 1 |
Huang, D; Li, Y; Luo, L; Wang, Z; Wen, R; Xia, X | 2 |
Blass, G; Israel, I; Reiners, C; Samnick, S | 1 |
Asai, N; Hara, A; Hoshino, T; Ida-Eto, M; Jijiwa, M; Kato, M; Nakashima, T; Ohgami, N; Sakashita, N; Shimada, A; Sobue, G; Sone, M; Tabuchi, K; Takahashi, M; Tsuzuki, T; Yamamoto, M | 1 |
Fornace, AJ; Gonzalez, FJ; Idle, JR; Krausz, KW; Manna, SK; Patterson, AD; Yang, Q | 1 |
Aromando, RF; Garabalino, MA; Heber, EM; Itoiz, ME; Miller, M; Molinari, AJ; Monti Hughes, A; Nigg, DW; Pozzi, EC; Schwint, AE; Thorp, S; Trivillin, VA | 1 |
Coelho, J; Cortes, MX; Dalazen, G; Dutra-Filho, CS; Jacques, CE; Mazzola, PN; Mescka, CP; Moraes, TB; Piccoli, B; Rosa, AP; Terra, M | 1 |
Jiang, X; Liu, J; Peng, S; Wang, W; Wang, Y; Wu, G; Wu, J; Yang, Y; Zhao, M; Zheng, M | 1 |
Aromando, RF; Garabalino, MA; Heber, EM; Itoiz, ME; Miller, M; Molinari, AJ; Monti Hughes, A; Nigg, DW; Pozzi, EC; Schwint, AE; Thorp, SI; Trivillin, VA | 1 |
Ichinose, H; Kume, A; Mizukami, H; Ozawa, K; Sanechika, S; Sumi-Ichinose, C; Urabe, M; Yagi, H | 1 |
Li, F; Liu, X; Lu, X; Xiong, Z; Zhang, S; Zheng, S | 1 |
Hutchison, RE; Mohi, G; Yan, D | 1 |
Chevessier, F; Girard, E; Krejci, E; McArdle, JJ; Mersdorf, U; Peter, C; Witzemann, V | 1 |
Clayton, TA | 1 |
Cerreto, M; Daniele, A; Mehdawy, B; Nisticò, R; Ombrone, D; Pastore, L; Ruoppolo, M; Salvatore, F; Usiello, A | 1 |
Martinez, A; Sarkissian, CN; Scherer, T; Thöny, B; Ying, M | 1 |
Caffrey, CR; Lantz, LD; Vermeire, JJ | 1 |
McBride, KL; Seagraves, NJ | 1 |
Chen, L; Dong, XC; Jones, DR; Liu, S; Shen, W; Tao, R; Wang, L; Wei, D; Yu, ZH; Zhang, S; Zhang, ZY | 1 |
Gadek, TR; O'Neill, CA; Pearlman, E; Sun, Y; Zhang, R | 1 |
Coelho, JG; Dalazen, GR; Dutra-Filho, CS; Jacques, CE; Moraes, TB; Rosa, AP; Terra, M | 1 |
Aguiar, AS; Berthiau, AS; Caussanel, S; Chevarin, C; Farrington, DT; Hamon, M; Herrick-Davis, K; Lanfumey, L; Madjar, JJ; Martin, CB; Mongeau, R; Ramond, F | 1 |
Andriolo, M; Calì, F; McDonald, JD; Mirisola, M; Puglisi-Allegra, S; Romano, V; Sarkissian, CN; Smith, CB | 1 |
Espinar, A; Guerrero, JM; Marchante, C; Martinez-Cruz, F; Osuna, C; Pozo, D | 1 |
Medeiros, DM; Yannicelli, S | 1 |
Napoli, C | 1 |
Anglard, P; Bonnafous, S; Chavey, C; Mari, B; Monthouel, MN; Tartare-Deckert, S; Van Obberghen, E | 1 |
Buhr, HJ; Foitzik, T; Hines, OJ; Hotz, B; Hotz, HG; Reber, HA | 1 |
Gellerich, FN; Neuhof, C; Trumbeckaite, S; Zierz, S | 1 |
Cabib, S; Pascucci, T; Puglisi-Allegra, S; Romano, V; Ventura, R | 1 |
Pfefferkorn, T; Rosenberg, GA | 1 |
Dyer, CA; Joseph, B | 1 |
Ezell, E; Jinga, W; Matalon, KM; Matalon, R; Quast, M; Surendran, S; Szucs, S; Tyring, S | 1 |
Allen, GC; Brooke, SL; Day, JC; Heard, PJ; Oyedepo, AC; Patel, H | 1 |
Lee, SR; Lo, EH; Tsuji, K | 1 |
Abraham, WM; Andrade-Gordon, P; Carolyn Fisher, M; Damiano, BP; de Garavilla, L; Dyatkin, AB; Fisher, MC; He, W; Hlasta, DJ; Hoekstra, WJ; Hornby, PJ; Kimball, ES; Kinney, WA; Kontoyianni, M; Maryanoff, BE; Prouty, SM; Santulli, RJ | 1 |
Kitahara, Y; Miura, K; Mori, Y; Tajima, N | 1 |
Dennis, DM; Glushakov, AV; Kagiyama, T; Martynyuk, AE; Ozcan, MS; Phillips, MI; Roose, B; Seubert, CN; Sumners, C | 1 |
Gropper, SS; Medeiros, DM; White, BD; Yannicelli, S | 1 |
Arnold, LA; Egami, K; Hyland, K; Jinnah, HA; Kasim, S | 1 |
Bentley, L; Browne, M; Cox, RD; Goldsworthy, M; Haynes, A; Hough, T; Hugill, A; Hunter, AJ; Mijat, V; Moir, L; Quarterman, J; Spurr, N; Toye, AA | 1 |
Aleshin, AN; Matsuda, H; Miyamoto, Y; Ono, M; Ryugo, M; Sawa, Y | 1 |
Jo, I; Jung, SC; Kang, S; Oh, HJ; Park, ES | 1 |
Bajpai, LK; Baker, SP; Dennis, DM; Embury, JE; Glushakov, AV; Glushakova, O; Laipis, PJ; Martynyuk, AE; Otero, DH; Seubert, CN; Sumners, C; Varshney, M | 1 |
Hellwig, D; Kirsch, CM; Menger, MD; Menges, M; Moellers, MO; Romeike, BF; Samnick, S; Schneider, G | 1 |
Bozic, M; Budihna, MV; Cerne, M; Drevensek, G; Peternel, L; Stalc, A; Stegnar, M; Urleb, U; Zega, A | 1 |
Achten, E; Bauwens, M; Cornelissen, B; Dierckx, RA; Kersemans, K; Kersemans, V; Mertens, J; Slegers, G | 1 |
Battistini, B; Blouin, A; Daull, P; Jeng, AY; Nantel, F; Sirois, P | 1 |
Beutler, B; Ding, L; Du, X; Gong, X; Horwitz, J; Huang, Q; Liu, H; McDonald, HW; Wang, M; Yates, JR | 1 |
Alhonen, L; Christensen, R; Jakobsen, M; Jensen, TG; Wahlfors, J | 1 |
Al-Dhalimy, M; Clark, H; Finegold, M; Grompe, M; Hamman, K; Harding, CO; Montini, E | 1 |
Jiang, YB; Lin, XT; Sun, DY; Sun, X; Yan, WL | 1 |
Jo, I; Jung, SC; Kang, S; Koo, SK; Lee, H; Oh, HJ; Park, JW; Rhee, H | 1 |
Ashokkumar, N; Pari, L | 1 |
Guerrero, JM; Martínez-Cruz, F; Osuna, C | 1 |
Bacher, K; Cornelissen, B; De Spiegeleer, B; Dierckx, RA; Kersemans, K; Kersemans, V; Mertens, J; Slegers, G; Thierens, H | 1 |
Alfón, J; Cortijo, J; Gómez, LA; Iranzo, A; Merlos, M; Montesinos, JL; Morcillo, EJ; Nabah, YN; Sanz, MJ | 1 |
De Spiegeleer, B; Kersemans, V; Mertens, J; Slegers, G | 1 |
Chung, JH; Kim, JM; Laipis, P; Lee, YJ; Oh, SP; Park, S; Park, YS; Peris, J; Yang, S | 1 |
Almstead, NG; Baker, TR; Brown, KK; De, B; Heitmeyer, SA; Hookfin, EB; Hsieh, LC; Janusz, MJ; Natchus, MG; Patel, V; Peng, SX; Pikul, S; Taiwo, YO | 1 |
Armstrong, C; Durkin, AJ; Osborne, DA; Rosemurgy, AS; Yeatman, TJ; Zervos, EE | 1 |
Batistoni, D; Gonzalez, BN; Heber, EM; Itoiz, ME; Kreimann, EL; Nigg, DW; Rebagliati, RJ; Schwint, AE; Trivillin, VA | 1 |
Fukui, K; Maruhashi, J; Tajima, N; Tojo, A; Uesato, N | 1 |
Erkent, U; Ertunc, M; Guc, MO; Ilhan, M; Iskit, AB; Onur, R | 1 |
Ali, SF; Charron, CE; Embury, JE; Laipis, PJ; Liu, B; Martynyuk, A; Rowland, NE; Zori, AG | 1 |
Estrada, EY; Mobashery, S; Rosenberg, GA | 1 |
Bilkei-Gorzo, A; Michel, K; Noble, F; Roques, BP; Zimmer, A | 1 |
Carney, PR; Dennis, DM; Laipis, PJ; Martynyuk, AE; Norman, WM; Ucar, DA; Yang, DD | 1 |
Blaumann, H; Bumaschny, E; Calzetta, O; Cardoso, JE; Heber, EM; Itoiz, ME; Longhino, J; Nigg, DW; Pozzi, E; Schwint, AE; Trivillin, VA | 1 |
Libert, C; López-Otin, C; Shapiro, S; Van Laere, I; Van Lint, P; Van Roy, M; Wielockx, B; Wilson, C | 1 |
Dagrosa, MA; Juvenal, GJ; Pisarev, MA | 1 |
Castillo, L; Erez, A; Lee, B; Marini, JC | 1 |
Andresen, JH; Escrig, R; Saugstad, OD; Solberg, R; Vento, M | 1 |
Dong, F; Ren, J; Sreejayan, N; Yang, X | 1 |
Kajioka, T; Kitahara, Y; Mine, T; Miura, K | 1 |
Etzel, MR; Hull, AK; Liu, X; Ney, DM; van Calcar, SC | 1 |
Cullen, DE; Doukas, J; Gilliland, DG; Gozo, M; Hood, JD; Kharas, MG; Ko, YD; Lee, BH; Leeman, DS; Levine, RL; Mak, CC; Martin, M; McDowell, EP; Moore, SA; Noronha, G; Okabe, R; Soll, RM; Tefferi, A; Wernig, G | 1 |
Dwivedy, AK; Shah, SN | 2 |
Chamove, AS | 1 |
Johnson, RC; Shah, SN | 1 |
Benevenga, NJ; Steele, RD | 1 |
Lane, JD; Langenbeck, U; Neuhoff, V; Schöne, B | 1 |
Lane, JD; Neuhoff, V | 1 |
Lo, GS; Longenecker, JB | 1 |
Berry, HK; Butcher, RE; Vorhees, CV | 1 |
Lipovac, K; Zanić-Grubisić, T | 1 |
Sancilio, LF; Sleevi, MC; Walsh, DA | 1 |
Blumstein, L; Levitsky, DA; Strupp, BJ | 1 |
Esmail, A; Fears, R; Ferres, H; Rush, WR; Walker, P | 1 |
Ambrus, CM; Ambrus, JL; Anthone, S; Cooley, C; Horváth, C; Kalghatgi, K; Mirand, EA; Sharma, SD | 1 |
Chakravarti, RN; Mitra, SK; Narasimharao, KL; Rani, VU; Sarkar, AK; Sidhu, GS | 1 |
Huether, G; Neuhoff, V | 1 |
Eller, AG; Hommes, FA; Taylor, EH | 1 |
Huether, G; Kaus, R; Neuhoff, V | 1 |
Burri, R; Herschkowitz, N; Reynolds, R | 1 |
Ciaramitaro, V; Diamond, A; Djali, S; Donner, E; Robinson, MB | 1 |
Bengtsson, F; Bergqvist, PB; Bosman, DK; Chamuleau, RA; Hjorth, S; Maas, MA; Vogels, BA | 1 |
Bourget, L; Chang, TM; Lister, C | 1 |
Bilaniuk, I; Moyse, J; O'Connor, MM; Slonim, AE; Teichberg, S; Zdanowicz, MM | 1 |
Diamond, A | 2 |
Bywaters, A; Coderre, JA; Hopewell, JW; Liu, HB; Micca, PL; Morris, GM; Nawrocky, MM | 1 |
Cunha-Filho, JS; Milton, C; Sarkis, JJ; Schetinger, MR; Teixeira, MV; Wajner, M; Wannmacher, D; Wyse, AT | 1 |
Asano, S; Hashimoto, E; Kira, Y; Nakaoka, T; Okabe, F; Sekine, I | 1 |
Grecksch, G; Rüthrich, HL; Schmidt, R | 1 |
Brown, PD; Crimmin, MJ; Fu, X; Hoffman, RM; Wang, X | 1 |
Hommes, FA | 1 |
Imamura, T; Isshiki, G; Nakajima, T; Oura, T; Sawada, Y; Shintaku, H | 1 |
Dove, WF; McDonald, JD; Shedlovsky, A; Symula, D | 1 |
Ido, T; Ishiwata, K; Kubota, K; Kubota, R; Tada, M; Yamada, S | 1 |
Dove, WF; Shedlovsky, A; Symula, DJ | 1 |
Dove, WF; Guillery, EN; Shedlovsky, A; Symula, DJ | 1 |
Gubkina, HA; Kachur, VA; Lepekhin, EA; Ushakova, GA | 1 |
Dyer, CA; Gailis, L; Kirby, ML; McDonald, JD | 1 |
Bigatel, DA; Carey, DJ; Cizmeci-Smith, G; Elmore, JR; Franklin, DP; Youkey, JR | 1 |
Blain, F; Chang, TM; Heft, R; Peevers, R; Sarkissian, CN; Scriver, CR; Shao, Z; Su, H | 1 |
Das, A; McGuire, PG; McLamore, A; Song, W | 1 |
Boulais, DM; McDonald, JD; Sarkissian, CN; Scriver, CR | 1 |
Campbell, CA; Chapman, GA; Harrison, D; Moores, K; Stewart, BR; Strijbos, PJ | 1 |
Daikhin, E; Dyer, CA; Jean-Guillaume, D; Kendler, A; Nguyen, LB; Shefer, S; Tint, GS; Yudkoff, M | 1 |
Balkwill, FR; Dias, S; Holdsworth, H; Scott, KA | 1 |
Alexander, B; Benjamin, IS; Li, X; Preston, JE; Segal, MB; Sherwood, R | 1 |
Chapman, DF; Lapchak, PA; Zivin, JA | 1 |
Haefele, MJ; McDonald, JD; White, G | 1 |
Gretz, N; Kränzlin, B; Morente, N; Obermüller, N; Witzgall, R | 1 |
Huszagh, VA; Infante, JP | 1 |
Howard, RB; Johnston, MR; Mullen, JB; Pagura, ME | 1 |
Attaix, D; Debiton, E; Knowles, AL; Madelmont, JC; Samuels, SE; Tilignac, T | 1 |
Artese, L; di Mola, FF; Di Sebastiano, P; Innocenti, P; Mascetta, G; Pernthaler, H; Rossi, C | 1 |
Duriez, M; Levy, BI; Mallat, Z; Silvestre, JS; Tamarat, R; Tedgui, A | 1 |
Mao, L; Sun, K; Yu, S | 1 |
Cho, S; McDonald, JD | 1 |
Blaumann, H; Calzetta, O; Itoiz, ME; Kreimann, EL; Longhino, J; Schwint, AE | 1 |
Batistoni, D; Dagrosa, A; Farías, S; Garavaglia, R; Itoiz, ME; Kreimann, EL; Schwint, AE | 1 |
Anderson, RL; Bissell, MJ; Le Beyec, J | 1 |
Bhagat, S; Che, M; Cher, ML; Fridman, R; Herzog, M; Mullins, C; Nemeth, JA; Shekarriz, B; Upadhyay, J; Yousif, R | 1 |
Al-Dhalimy, M; Finegold, M; Grompe, M; Overturf, K | 1 |
Calderon-Ramirez, L; Frösen, J; Häyry, P; Myllärniemi, M | 1 |
Lo, EH; Sumii, T | 1 |
Aykin-Burns, N; Ercal, N; Gurer-Orhan, H; McDonald, JD | 1 |
Bruins, MJ; Deutz, NE; Lamers, WH; Soeters, PB | 1 |
Banai, S; Fishbein, I; Gertz, SD; Golomb, G; Margolin, L; Perez, LS; Reich, R | 1 |
Chamove, AS; Molinaro, TJ | 1 |
Avins, L; Guroff, G; Kuwabara, T | 1 |
Andersen, AE; Fales, HM; Guroff, G; Pisano, JJ; Rowe, VD | 1 |
Antonas, KN; Coulson, WF | 1 |
Brown, WJ; Copenhaver, JH; Gunter, R; Schalock, RL | 1 |
Elias, JM; Feinstein, G; Janoff, A; Malemud, CJ | 1 |
Delvalle, JA; Greengard, O | 1 |
Dhondt, JL; Farriaux, JP | 1 |
Biserte, G; Dautrevaux, M; Dhondt, JL; Farriaux, JP | 1 |
Loo, YH; Scotto, J; Wisniewski, HM | 1 |
Benavides, J; Gimenez, C; Mayor, F; Sanchez-Rubiales, M; Valdivieso, F | 1 |
Chan, W; Kopple, JD; Siassi, F; Swendseid, ME; Tam, CF; Vyhmeister, I; Wang, M | 1 |
Colmant, G | 1 |
Fisher, JE; Hodgman, J; James, JH; Rosen, HM; Soeters, PB | 1 |
Ambrus, CM; Ambrus, JL; Guthrie, R; Horvath, C; Kant, C; Mirand, E; Paul, T; Pedersen, H; Sharma, S | 1 |
Berry, HK; Brunner, RL; Butcher, RE; McLean, MS; Vorhees, CV | 1 |
Barthon, F; Charpentier, C; Domange, C; Laggoune, B; Lemonnier, A; Wolf, M | 1 |
Borisy, GG; Rodriguez, JA | 1 |
Del Valle, JA; Greengard, O; Yoss, MS | 1 |
Cummings, MG; Fischer, JE; James, JH; Kean, JM; Soeters, PB | 1 |
Hunt, R; Mertin, J | 1 |
Andersen, A | 1 |
Frazer, A; Mendels, J | 1 |
Kao, R; Morgan, HE; Rannels, DE | 1 |
Hijikata-Okunomiya, A; Katsuura, Y; Okada, Y; Okamoto, S; Wanaka, K | 1 |
Coderre, J; Fairchild, R; Hansrote, J; Packer, S; Perry, H; Saraf, S | 1 |
Oparina, TI; Putilina, FE | 1 |
Bespalova, MA; Chaeva, LS; Kliaich, K; Maksimova, SP; Mukhina, AP | 1 |
Zuber, VL | 1 |
Hatta, S; Honda, C; Ichihashi, M; Mishima, Y | 1 |
Bode, VC; Dove, WF; McDonald, JD; Shedlovsky, A | 1 |
Christensen, HN; de Cespedes, C; Lowler, K; Thoene, JG | 1 |
Sze, PY | 1 |
Chow, IZ; Inoue, A; Isshiki, G; Okano, Y; Oura, T | 1 |
Boylan, J; Ellenbogen, R; Pueschel, SM | 1 |
Cotton, RG | 1 |
Bode, VC; McDonald, JD | 1 |
Elliott, RB; Lewis, SA; Lyon, IC | 1 |
Boylan, JM; Povar, ML; Pueschel, SM; Schrier, AM | 1 |
Gerritsen, T; Siegel, FL | 1 |
Chang, AY | 1 |
Andersen, AE; Guroff, G | 1 |
Masek, K; Rasková, H; Rotta, J | 1 |
Brown, WJ; Gunter, R; Schalock, R | 1 |
Copenhaver, JH; Schalock, RL | 1 |
Carver, MJ; Copenhaver, JH; Schalock, RL | 1 |
Tourian, A | 1 |
Koprowski, H | 1 |
Norton, AL; Pihlaja, DJ | 1 |
Daftari, B; Fishman, MA; Prensky, AL | 1 |
Andersen, AE; Guroff, G; Rowe, V | 1 |
Seller, MJ | 1 |
Adelman, LS; Bass, NH; Caley, DW; Mann, JD | 1 |
Herron, WL; Riegel, BW | 1 |
Brennan, E; Herron, WL; Riegel, BW; Rubin, ML | 1 |
Shoma, N | 1 |
Chamove, AS; Davenport, JW | 1 |
Costantini, ML; Grümer, HD; Hetland, LB | 1 |
Kozik, M | 1 |
Haufe, F; Haufe, U; Lubs, H; Machill, G | 1 |
Child, CG; Coon, WW; Iob, V; Mattson, WJ; Sloan, M; Turcotte, JG | 1 |
Aoki, K; Siegel, FL | 1 |
Mitoma, C; Pryor, GT | 1 |
Bory, P; Jakubovic, A; Woolf, F; Woolf, LI | 1 |
McKean, CM; Peterson, NA; Shah, SN | 1 |
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
10 review(s) available for phenylalanine and Disease Models, Animal
Article | Year |
---|---|
State-of-the-Art 2019 on Gene Therapy for Phenylketonuria.
Topics: Animals; Biomarkers; Clinical Trials as Topic; Dependovirus; Disease Models, Animal; Gene Editing; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; Humans; Liver; Mice; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias; Plasmids | 2019 |
Neurophysiological symptoms and aspartame: What is the connection?
Topics: Affect; Animals; Aspartame; Aspartic Acid; Brain; Cognitive Dysfunction; Disease Models, Animal; Dopamine; Free Radicals; Humans; Hydrocortisone; Migraine Disorders; Nervous System Diseases; Neurotransmitter Agents; Non-Nutritive Sweeteners; Norepinephrine; Oxidative Stress; Phenylalanine; Seizures; Serotonin; Sleep Initiation and Maintenance Disorders | 2018 |
Boron neutron capture therapy in cancer: past, present and future.
Topics: Animals; Boron Compounds; Boron Neutron Capture Therapy; Cell Line, Tumor; Deuteroporphyrins; Disease Models, Animal; Dogs; Humans; Mice; Mice, Nude; Phenylalanine; Radiation-Sensitizing Agents; Thyroid Neoplasms | 2007 |
Adverse effects of excessive consumption of amino acids.
Topics: Amino Acid Metabolism, Inborn Errors; Amino Acids; Animals; Brain; Cattle; Diet; Disease Models, Animal; Ethionine; Fenclonine; Glycine; Growth Disorders; Histidine; Humans; Methionine; Nerve Tissue Proteins; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias; Pneumonia, Atypical Interstitial, of Cattle; Serine; Stereoisomerism; Sulfhydryl Compounds; Tissue Distribution; Tryptophan; Tyrosine; Vitamin A | 1984 |
Progress in experimental phenylketonuria: a critical review.
Topics: Abnormalities, Multiple; Animals; Disease Models, Animal; Energy Metabolism; Female; Fenclonine; Glutamates; Humans; Mice; Myelin Sheath; Phenylalanine; Phenylketonurias; Pregnancy; Pregnancy Complications; Protein Biosynthesis; Pyridoxine; Serotonin | 1981 |
Phenylalanine levels of 6-10 mg/dl may not be as benign as once thought.
Topics: Animals; Case-Control Studies; Cerebral Cortex; Cognition Disorders; Contrast Sensitivity; Cross-Sectional Studies; Disease Models, Animal; Humans; Longitudinal Studies; Phenylalanine; Phenylketonurias; Rats | 1994 |
Evidence for the importance of dopamine for prefrontal cortex functions early in life.
Topics: Animals; Child, Preschool; Cognition; Disease Models, Animal; Dopamine; Humans; Infant; Inhibition, Psychological; Macaca; Neural Pathways; Phenylalanine; Phenylketonurias; Prefrontal Cortex; Spatial Behavior; Task Performance and Analysis; Tyrosine; Visual Pathways | 1996 |
Impaired arachidonic (20:4n-6) and docosahexaenoic (22:6n-3) acid synthesis by phenylalanine metabolites as etiological factors in the neuropathology of phenylketonuria.
Topics: Adult; Animals; Arachidonic Acid; Brain; Brain Diseases, Metabolic; Child; Disease Models, Animal; Docosahexaenoic Acids; Female; Humans; Infant; Infant, Newborn; Male; Mice; Mitochondria; Models, Biological; Phenylalanine; Phenylketonuria, Maternal; Phenylketonurias; Pregnancy | 2001 |
Urinary phenylalanine metabolites in preweanling rats treated with p-chlorophenylalanine and phenylalanine.
Topics: Animals; Disease Models, Animal; Fenclonine; Humans; Lactates; Phenylalanine; Phenylketonurias; Phenylpyruvic Acids; Rats | 1975 |
Pharmacological effects of phenylalanine on seizure susceptibility: an overview.
Topics: Animals; Aspartame; Dipeptides; Disease Models, Animal; Disease Susceptibility; Humans; Phenylalanine; Seizures | 1989 |
318 other study(ies) available for phenylalanine and Disease Models, Animal
Article | Year |
---|---|
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Gene expression profiles in the brain of phenylketonuria mouse model reversed by the low phenylalanine diet therapy.
Topics: Animals; Brain; Disease Models, Animal; Mice; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias; Transcriptome | 2021 |
Correlations of blood and brain biochemistry in phenylketonuria: Results from the Pah-enu2 PKU mouse.
Topics: Amino Acids; Animals; Brain; Brain Chemistry; Disease Models, Animal; Mice; Mice, Inbred C57BL; Neurotransmitter Agents; Phenylalanine; Phenylketonurias | 2021 |
Blood phenylalanine reduction reverses gene expression changes observed in a mouse model of phenylketonuria.
Topics: Animals; Biomarkers; Brain; Disease Models, Animal; Down-Regulation; Gene Expression Profiling; Genetic Therapy; Liver; Male; Mice, Knockout; Phenylalanine; Phenylalanine Ammonia-Lyase; Phenylalanine Hydroxylase; Phenylketonurias; Proteome; Proteomics; Transcriptome | 2021 |
Efficacy of Boron Neutron Capture Therapy in Primary Central Nervous System Lymphoma: In Vitro and In Vivo Evaluation.
Topics: Animals; Apoptosis; Boron; Boron Neutron Capture Therapy; Brain; Cell Line, Tumor; Cell Survival; Central Nervous System Neoplasms; Cranial Irradiation; Disease Models, Animal; Humans; Lymphoma; Methotrexate; Mice; Phenylalanine; Tissue Distribution | 2021 |
The increasing importance of LNAA supplementation in phenylketonuria at higher plasma phenylalanine concentrations.
Topics: Amino Acids, Neutral; Animals; Dietary Supplements; Disease Models, Animal; Humans; Mice; Phenylalanine; Phenylketonurias | 2022 |
The effect of casein glycomacropeptide versus free synthetic amino acids for early treatment of phenylketonuria in a mice model.
Topics: Amino Acids; Animals; Bone and Bones; Bone Density; Brain; Caseins; Dietary Supplements; Disease Models, Animal; Female; Maze Learning; Mice; Mice, Inbred C57BL; Peptide Fragments; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias; Serotonin; Tyrosine | 2022 |
Modeling the cognitive effects of diet discontinuation in adults with phenylketonuria (PKU) using pegvaliase therapy in PAH-deficient mice.
Topics: Adult; Animals; Cognition; Diet; Disease Models, Animal; Female; Humans; Mice; Mice, Inbred C57BL; Phenylalanine; Phenylalanine Ammonia-Lyase; Phenylalanine Hydroxylase; Phenylketonurias; Recombinant Proteins | 2022 |
Oral administration of phenylalanine molecularly imprinted polymer (MIP) benefits PKU mouse model.
Topics: Administration, Oral; Animals; Disease Models, Animal; Mice; Molecularly Imprinted Polymers; Phenylalanine; Phenylketonurias | 2022 |
An exercise-inducible metabolite that suppresses feeding and obesity.
Topics: Adiposity; Animals; Body Weight; Diabetes Mellitus, Type 2; Disease Models, Animal; Eating; Energy Metabolism; Feeding Behavior; Glucose; Lactic Acid; Mice; Obesity; Phenylalanine; Physical Conditioning, Animal | 2022 |
Evaluation of the Key Advantages between Two Modalities of Boronophenylalanine Administration for Clinical Boron Neutron Capture Therapy Using an Animal Model.
Topics: Animals; Boron; Boron Compounds; Boron Neutron Capture Therapy; Brain Neoplasms; Carcinoma, Squamous Cell; Disease Models, Animal; Humans; Mouth Neoplasms; Phenylalanine | 2022 |
Comparative Analysis of Host Metabolic Alterations in Murine Malaria Models with Uncomplicated or Severe Malaria.
Topics: Animals; Arginine; Bile Acids and Salts; Bile Pigments; Disease Models, Animal; Hippurates; Histidine; Hormones; Humans; Malaria, Cerebral; Mice; Ornithine; Phenylalanine; Plasmodium berghei; Sphingolipids; Valine | 2022 |
Effects of Donepezil Treatment on Brain Metabolites, Gut Microbiota, and Gut Metabolites in an Amyloid Beta-Induced Cognitive Impairment Mouse Pilot Model.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Cognitive Dysfunction; Disease Models, Animal; Donepezil; Gastrointestinal Microbiome; Glutamic Acid; Glycerol; Hypoxanthines; Inosine; Mice; Oxalates; Phenylalanine; Pyrrolidonecarboxylic Acid; Xylose | 2022 |
Bergamot polysaccharides relieve DSS-induced ulcerative colitis via regulating the gut microbiota and metabolites.
Topics: Animals; Colitis; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Models, Animal; Gastrointestinal Microbiome; Inflammation; Mice; Mice, Inbred C57BL; Phenylalanine; Polysaccharides | 2023 |
Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer's disease progression.
Topics: Alzheimer Disease; Amino Acids; Animals; Anti-Bacterial Agents; Bacteria; Clinical Trials, Phase III as Topic; Cognitive Dysfunction; Disease Models, Animal; Disease Progression; Gastrointestinal Microbiome; Humans; Isoleucine; Mannose; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microglia; Oligosaccharides; Phenylalanine; Th1 Cells | 2019 |
Of mice and men: Plasma phenylalanine reduction in PKU corrects neurotransmitter pathways in the brain.
Topics: Amino Acids; Animals; Biomarkers; Biosynthetic Pathways; Brain; Disease Models, Animal; Humans; Male; Mice; Mice, Knockout; Mutation; Neurotransmitter Agents; Phenylalanine; Phenylalanine Ammonia-Lyase; Phenylalanine Hydroxylase; Phenylketonurias; Recombinant Proteins; Treatment Outcome | 2019 |
Poly(vinyl alcohol) boosting therapeutic potential of
Topics: Animals; Boron Compounds; Boron Neutron Capture Therapy; Cell Line, Tumor; Disease Models, Animal; Drug Synergism; Energy Metabolism; Humans; Mass Spectrometry; Mice; Neoplasms; Phenylalanine; Polyvinyl Alcohol; Radiation-Sensitizing Agents; Signal Transduction; Tissue Distribution; Xenograft Model Antitumor Assays | 2020 |
Plasma Metabolomic Changes in Mice With Time-restricted Feeding-attenuated Spontaneous Metastasis of Lewis Lung Carcinoma.
Topics: alpha-Tocopherol; Animals; Carcinoma, Lewis Lung; Cholestanol; Cholesterol; Diet, High-Fat; Disease Models, Animal; Docosahexaenoic Acids; Fasting; Humans; Insulin; Isoleucine; Lactic Acid; Leucine; Metabolomics; Mice; Neoplasm Metastasis; Phenylalanine; Pyruvic Acid | 2020 |
A novel Pah-exon1 deleted murine model of phenylalanine hydroxylase (PAH) deficiency.
Topics: Animals; CRISPR-Cas Systems; Disease Models, Animal; Exons; Gene Editing; Genetic Vectors; Humans; Liver; Mice; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias | 2020 |
A porcine model of phenylketonuria generated by CRISPR/Cas9 genome editing.
Topics: Adolescent; Adult; Animals; CRISPR-Cas Systems; Diet; Disease Models, Animal; Gene Editing; Humans; Liver; Phenotype; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias; Swine | 2020 |
Selective Detection of Nano-Sized Diagnostic Markers Using Au-ZnO Nanorod-Based Surface-Enhanced Raman Spectroscopy (SERS) in Ureteral Obstruction Models.
Topics: Animals; Biomarkers; Collagen; Disease Models, Animal; Female; Fibrosis; Gold; Kidney; Kidney Diseases; Nanotubes; Phenylalanine; Rats, Sprague-Dawley; Spectrum Analysis, Raman; Ureteral Obstruction; Urinalysis; Zinc Oxide | 2020 |
Repeat-dose animal toxicity studies and genotoxicity study with deactivated alkaline serine protease (DASP), a protein low in phenylalanine (PHE).
Topics: Animals; Diet; Disease Models, Animal; Drug Administration Schedule; Escherichia coli; Female; Humans; Male; Mutagenicity Tests; Phenylalanine; Phenylketonurias; Rats; Rats, Sprague-Dawley; Salmonella typhimurium; Serine Endopeptidases | 2020 |
Mesenchymal stem cell energy deficit and oxidative stress contribute to osteopenia in the Pah
Topics: Alkaline Phosphatase; Animals; Bone Density; Bone Diseases, Metabolic; Cell Differentiation; Disease Models, Animal; Humans; Mesenchymal Stem Cells; Mice; Osteoblasts; Oxidative Stress; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias; Resveratrol | 2021 |
Stepwise candidate drug screening for myopia control by using zebrafish, mouse, and Golden Syrian Hamster myopia models.
Topics: Animals; Atropine; Cricetinae; Disease Models, Animal; Drug Evaluation, Preclinical; Embryo, Nonmammalian; Hydroxamic Acids; Lumican; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred C57BL; Morpholinos; Myopia; Phenylalanine; Sclera; Thiophenes; Tissue Inhibitor of Metalloproteinase-2; Zebrafish; Zebrafish Proteins | 2021 |
Use of an adeno-associated virus serotype Anc80 to provide durable cure of phenylketonuria in a mouse model.
Topics: Animals; Cell Line; Dependovirus; Disease Models, Animal; DNA, Recombinant; Female; Genetic Therapy; Genetic Vectors; Hair Color; Humans; Injections, Intravenous; Liver; Male; Mice; Mice, Inbred C57BL; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias; Transduction, Genetic | 2021 |
Mass spectrometry-based urinary metabolomics for exploring the treatment effects of Radix ginseng-Schisandra chinensis herb pair on Alzheimer's disease in rats.
Topics: Alzheimer Disease; Animals; Biomarkers; Brain; Disease Models, Animal; Drugs, Chinese Herbal; Gastrointestinal Microbiome; Inflammation; Mass Spectrometry; Medicine, Chinese Traditional; Metabolomics; Nervous System; Panax; Phenylalanine; Plant Extracts; Rats; Reproducibility of Results; Schisandra; Tandem Mass Spectrometry; Tyrosine; Urinalysis | 2021 |
Dysregulated Phenylalanine Catabolism Plays a Key Role in the Trajectory of Cardiac Aging.
Topics: Aging; Amino Acids; Animals; Biomarkers; Biopterins; Catalysis; Cellular Senescence; Disease Models, Animal; Disease Susceptibility; Heart Diseases; Humans; Liver; Male; Mice; Mice, Knockout; Models, Biological; Myocardium; Myocytes, Cardiac; Phenylalanine; Rats | 2021 |
A noncoding RNA modulator potentiates phenylalanine metabolism in mice.
Topics: Acetylgalactosamine; Animals; Biopterins; Diet; Disease Models, Animal; Female; Hepatocytes; Humans; Liver; Male; Mice; Mice, Knockout; Nucleic Acid Conformation; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias; Protein Binding; RNA, Long Noncoding | 2021 |
A New View of Bone Loss in Phenylketonuria.
Topics: Animals; Bone Diseases, Metabolic; Disease Models, Animal; Humans; Mice; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias | 2021 |
Detection of Localized Hepatocellular Amino Acid Kinetics by using Mass Spectrometry Imaging of Stable Isotopes.
Topics: Animals; Carbon Isotopes; Carcinoma, Hepatocellular; Disease Models, Animal; Gas Chromatography-Mass Spectrometry; Heterografts; Hydroxylation; Kinetics; Liver Neoplasms; Mass Spectrometry; Mice; Mice, Nude; Phenylalanine; Reproducibility of Results; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Spectroscopy, Fourier Transform Infrared; Tandem Mass Spectrometry; Tyrosine | 2017 |
Partial rescue of neuropathology in the murine model of PKU following administration of recombinant phenylalanine ammonia lyase (pegvaliase).
Topics: Animals; Brain; Disease Models, Animal; Humans; Mice; Neurotransmitter Agents; Phenylalanine; Phenylalanine Ammonia-Lyase; Phenylketonurias; Recombinant Proteins; Tyrosine 3-Monooxygenase | 2017 |
Phenylalanine derivatives with modulating effects on human α1-glycine receptors and anticonvulsant activity in strychnine-induced seizure model in male adult rats.
Topics: Animals; Anticonvulsants; Convulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Glycine; HEK293 Cells; Humans; Ligands; Male; Membrane Potentials; Microinjections; Neuroblastoma; Oocytes; Oxidopamine; Patch-Clamp Techniques; Phenylalanine; Rats; Rats, Wistar; Receptors, Glycine; Seizures; Strychnine; Transduction, Genetic; Xenopus laevis | 2017 |
Ongoing Electroencephalographic Activity Associated with Cortical Arousal in Transgenic PDAPP Mice (hAPP V717F).
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Analysis of Variance; Animals; Arousal; Brain Mapping; Brain Waves; Cerebral Cortex; Disease Models, Animal; Electroencephalography; Fourier Analysis; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Phenylalanine; Valine | 2018 |
Enteric serotonin and oxytocin: endogenous regulation of severity in a murine model of necrotizing enterocolitis.
Topics: Animals; Animals, Newborn; Disease Models, Animal; Enterochromaffin Cells; Enterocolitis, Necrotizing; Enzyme Inhibitors; Inflammation; Intestinal Mucosa; Liver; Mice; Oxytocin; Phenylalanine; Pyrimidines; Serotonin; Serotonin Plasma Membrane Transport Proteins; Severity of Illness Index; Signal Transduction; Tryptophan Hydroxylase | 2017 |
l-phenylalanine modulates gut hormone release and glucose tolerance, and suppresses food intake through the calcium-sensing receptor in rodents.
Topics: Animals; Appetite Depressants; Appetite Regulation; Disease Models, Animal; Eating; Energy Metabolism; Gastrointestinal Hormones; Glucose Intolerance; Male; Mice; Mice, Inbred C57BL; Phenylalanine; Rats; Rats, Wistar; Receptors, Calcium-Sensing; Receptors, Gastrointestinal Hormone; Satiation | 2017 |
[Metabonomic analysis of the urine from rat model with abnormal sapra syndrome].
Topics: Amino Acids; Animals; Citric Acid; Creatine; Disease Models, Animal; Energy Metabolism; Glutamine; Glycoproteins; Isoleucine; Leucine; Metabolomics; Phenylalanine; Rats; Rats, Wistar; Syndrome | 2017 |
Large neutral amino acid supplementation as an alternative to the phenylalanine-restricted diet in adults with phenylketonuria: evidence from adult Pah-enu2 mice.
Topics: Amino Acids, Neutral; Animals; Biogenic Monoamines; Brain; Dietary Supplements; Disease Models, Animal; Eating; Female; Male; Mice, Inbred C57BL; Mice, Mutant Strains; Phenylalanine; Phenylketonurias | 2018 |
Chemical Proteomics Reveals Soluble Epoxide Hydrolase as a Therapeutic Target for Ocular Neovascularization.
Topics: Angiogenesis Inhibitors; Animals; Binding Sites; Choroidal Neovascularization; Chromones; Disease Models, Animal; Enzyme Inhibitors; Epoxide Hydrolases; Fatty Acids, Unsaturated; Humans; Mice, Inbred C57BL; Molecular Docking Simulation; Molecular Targeted Therapy; Phenylalanine; Protein Domains; Proteomics; Wet Macular Degeneration | 2018 |
Blood phenylalanine reduction corrects CNS dopamine and serotonin deficiencies and partially improves behavioral performance in adult phenylketonuric mice.
Topics: Animals; Central Nervous System Diseases; Cognitive Dysfunction; Disease Models, Animal; Dopamine; Humans; Mice; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias; Serotonin; Tryptophan Hydroxylase; Tyrosine 3-Monooxygenase | 2018 |
Secondary BH4 deficiency links protein homeostasis to regulation of phenylalanine metabolism.
Topics: Animals; Biopterins; Disease Models, Animal; Humans; Inactivation, Metabolic; Kinetics; Liver; Mice; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias; Protein Folding; Proteostasis | 2018 |
A new therapy prevents intellectual disability in mouse with phenylketonuria.
Topics: Administration, Intravenous; Anabaena; Animals; Brain Chemistry; Disease Models, Animal; Drug Delivery Systems; Drug Evaluation, Preclinical; Erythrocytes; Female; Intellectual Disability; Male; Mice; Mice, Knockout; Motor Activity; Phenylalanine; Phenylalanine Ammonia-Lyase; Phenylketonurias; Recombinant Proteins | 2018 |
Pharmacological Inhibition of the Ubiquitin Ligase RNF5 Rescues F508del-CFTR in Cystic Fibrosis Airway Epithelia.
Topics: Animals; Apoptosis; Benzamidines; Cell Proliferation; Cell Survival; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Disease Models, Animal; DNA-Binding Proteins; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epithelial Cells; Humans; Mice; Models, Molecular; Molecular Structure; Phenylalanine; Structure-Activity Relationship; Thiadiazoles; Ubiquitin-Protein Ligases | 2018 |
LatY136F knock-in mouse model for human IgG4-related disease.
Topics: Adaptor Proteins, Signal Transducing; Adrenal Cortex Hormones; Animals; Disease Models, Animal; Gene Knock-In Techniques; Humans; Immunoglobulin G4-Related Disease; Kidney; Leukocytes, Mononuclear; Lung; Membrane Proteins; Mice; Mutation; Pancreas; Phenotype; Phenylalanine; Phosphoproteins; Salivary Glands; Tyrosine | 2018 |
RGN-259 (thymosin β4) improves clinically important dry eye efficacies in comparison with prescription drugs in a dry eye model.
Topics: Animals; Conjunctiva; Cornea; Cyclosporine; Disease Models, Animal; Dry Eye Syndromes; Female; Goblet Cells; Humans; Inflammation Mediators; Lacrimal Apparatus; Male; Mice; Mice, Inbred NOD; Mucins; Ophthalmic Solutions; Phenylalanine; Polyphosphates; Prescription Drugs; Scopolamine; Sulfones; Tears; Thymosin; Treatment Outcome; Uracil Nucleotides | 2018 |
Inhibiting neutral amino acid transport for the treatment of phenylketonuria.
Topics: Amines; Amino Acid Transport Systems, Neutral; Amino Acids, Neutral; Animals; Astrocytes; Biological Transport; Brain; Disease Models, Animal; Female; Gene Expression Regulation; Genetic Diseases, Inborn; Kidney Tubules, Proximal; Male; Memory, Short-Term; Mice; Mice, Knockout; Morpholinos; Oligonucleotides; Phenylalanine; Phenylketonurias; Renal Reabsorption | 2018 |
Size-dependent anti-inflammatory activity of a peptide-gold nanoparticle hybrid in vitro and in a mouse model of acute lung injury.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Disease Models, Animal; Gold; Inflammation; Lipopolysaccharides; Metal Nanoparticles; Particle Size; Peptides; Phenylalanine | 2019 |
RNA-Seq analysis in an avian model of maternal phenylketonuria.
Topics: Animals; Chickens; Disease Models, Animal; Female; Heart Defects, Congenital; Metabolic Networks and Pathways; Phenotype; Phenylalanine; Phenylketonuria, Maternal; Pregnancy; Sequence Analysis, RNA; Transcriptome; Tretinoin; Zygote | 2019 |
Gene Editing Successfully Corrects 2 Amino Acid Disorders: In 2 preclinical studies using CRISPR-mediated gene editing, phenylketonuria and hereditary tyrosinemia type 1 were corrected.
Topics: Amino Acids; Animals; CRISPR-Cas Systems; Disease Models, Animal; Gene Editing; Humans; Hydrolases; Mice; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias; Tyrosine; Tyrosinemias | 2019 |
A novel GTPCH deficiency mouse model exhibiting tetrahydrobiopterin-related metabolic disturbance and infancy-onset motor impairments.
Topics: Animals; Biopterins; Brain; Disease Models, Animal; GTP Cyclohydrolase; Homozygote; Humans; Liver; Mice; Motor Disorders; Mutant Proteins; Mutation, Missense; Phenylalanine; Survival Rate | 2019 |
Neuroprotection of hydroxysafflor yellow A in experimental cerebral ischemia/reperfusion injury via metabolic inhibition of phenylalanine and mitochondrial biogenesis.
Topics: Animals; Behavior, Animal; Brain Ischemia; Chalcone; Disease Models, Animal; Energy Metabolism; Gene Expression Regulation, Enzymologic; Mice; Mitochondria; Neurons; Neuroprotective Agents; Organelle Biogenesis; Oxidative Stress; PC12 Cells; Phenylalanine; Quinones; Rats; Reperfusion Injury; Treatment Outcome | 2019 |
The novel butyrate derivative phenylalanine-butyramide protects from doxorubicin-induced cardiotoxicity.
Topics: Amides; Animals; Antibiotics, Antineoplastic; Apoptosis; Butyrates; Butyric Acid; Cardiotoxicity; Disease Models, Animal; Doxorubicin; Echocardiography; Mice; Mice, Inbred C57BL; Mitochondria; Myocytes, Cardiac; Oxidative Stress; Phenylalanine; Protective Agents; Treatment Outcome | 2019 |
Long-term dietary intervention with low Phe and/or a specific nutrient combination improve certain aspects of brain functioning in phenylketonuria (PKU).
Topics: Age Factors; Animals; Behavior, Animal; Brain; Disease Models, Animal; Female; Learning; Male; Memory; Mice; Mice, Knockout; Neurotransmitter Agents; Nutrients; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias | 2019 |
Development of an underivatized LC-MS/MS method for quantitation of 14 neurotransmitters in rat hippocampus, plasma and urine: Application to CUMS induced depression rats.
Topics: Animals; Blood Chemical Analysis; Chromatography, Liquid; Depression; Disease Models, Animal; Glutamic Acid; Hippocampus; Kynurenic Acid; Kynurenine; Limit of Detection; Linear Models; Male; Neurotransmitter Agents; Phenylalanine; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Tandem Mass Spectrometry; Tryptophan; Urinalysis | 2019 |
Creatine plus pyruvate supplementation prevents oxidative stress and phosphotransfer network disturbances in the brain of rats subjected to chemically-induced phenylketonuria.
Topics: Animals; Antioxidants; Blood-Brain Barrier; Brain; Creatine; Disease Models, Animal; Energy Metabolism; Oxidative Stress; Phenylalanine; Phenylketonurias; Pyruvic Acid; Rats; Rats, Wistar; Reactive Oxygen Species | 2019 |
Depletion of Jak2V617F myeloproliferative neoplasm-propagating stem cells by interferon-α in a murine model of polycythemia vera.
Topics: Amino Acid Substitution; Animals; Apoptosis; Cell Proliferation; Disease Models, Animal; Hematologic Neoplasms; Humans; Interferon-alpha; Janus Kinase 2; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutant Proteins; Neoplastic Stem Cells; Phenylalanine; Polycythemia Vera; Valine | 2013 |
In vitro and in vivo antitumor activity of a novel alkylating agent, melphalan-flufenamide, against multiple myeloma cells.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Alkylating; Cell Line, Tumor; Cell Movement; Cell Survival; Disease Models, Animal; Drug Synergism; Female; Humans; Melphalan; Mice; Multiple Myeloma; Neovascularization, Pathologic; Phenylalanine; Tumor Burden; Xenograft Model Antitumor Assays | 2013 |
Involvement of matrix metalloproteinases-2 and -9 in the formation of a lacuna-like cerebral cavity.
Topics: Analysis of Variance; Animals; CD11b Antigen; Disease Models, Animal; Ectodysplasins; Gene Expression Regulation, Enzymologic; Glial Fibrillary Acidic Protein; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Microglia; Minocycline; Phenylalanine; Protease Inhibitors; Rats; Rats, Wistar; Stroke; Stroke, Lacunar; Thiophenes; Time Factors | 2013 |
NOX, the main regulator in oxidative stress in experimental models of phenylketonuria?
Topics: Animals; Disease Models, Animal; Glutathione; Mice; NADPH Oxidases; Oxidative Stress; Phenylalanine; Phenylketonurias; Superoxides | 2013 |
Oral treatment with a novel small molecule alpha 4 integrin antagonist, AJM300, prevents the development of experimental colitis in mice.
Topics: Administration, Oral; Animals; Antibodies, Monoclonal; Biopsy, Needle; Cell Adhesion Molecules; Colitis, Ulcerative; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Delivery Systems; Female; Immunohistochemistry; Integrin alpha4; Male; Mice; Mice, Inbred BALB C; Phenylalanine; Quinazolinones; Random Allocation; Reference Values | 2013 |
Vortioxetine dose-dependently reverses 5-HT depletion-induced deficits in spatial working and object recognition memory: a potential role for 5-HT1A receptor agonism and 5-HT3 receptor antagonism.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Benzamides; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Indazoles; Maze Learning; Memory Disorders; Memory, Short-Term; Phenylalanine; Piperazines; Protein Binding; Pyridines; Rats; Rats, Long-Evans; Receptor, Serotonin, 5-HT1A; Receptors, Serotonin, 5-HT3; Recognition, Psychology; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT3 Receptor Antagonists; Sulfides; Time Factors; Tritium; Tropanes; Vortioxetine | 2014 |
Raman spectroscopy detection of molecular changes associated with two experimental models of osteoarthritis in rats.
Topics: Animals; Cartilage; Collagenases; Disease Models, Animal; Male; Motor Activity; Osteoarthritis; Osteoarthritis, Knee; Phenylalanine; Rats, Wistar; Spectrum Analysis, Raman; Tibia | 2014 |
Characterization of 2-(methylamino)alkanoic acid capacity to restrict blood-brain phenylalanine transport in Pah enu2 mice: preliminary findings.
Topics: Acids, Acyclic; Aminoisobutyric Acids; Animals; Blood-Brain Barrier; Brain; Disease Models, Animal; Humans; Isoleucine; Large Neutral Amino Acid-Transporter 1; Methylation; Mice; Mice, Transgenic; Molecular Targeted Therapy; Organ Specificity; Phenylalanine; Phenylketonurias; Protein Conformation; Protein Folding; Valine | 2013 |
Carrier-linked mutual prodrugs of biphenylacetic acid as a promising alternative to bioprecursor fenbufen: design, kinetics, and pharmacological studies.
Topics: Administration, Oral; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Arthritis, Rheumatoid; Disease Models, Animal; Drug Liberation; Female; Glycine; Humans; Inflammation; Male; Pain; Phenylacetates; Phenylalanine; Phenylbutyrates; Prodrugs; Rats; Rats, Wistar | 2014 |
Man made disease: clinical manifestations of low phenylalanine levels in an inadequately treated phenylketonuria patient and mouse study.
Topics: Alopecia; Animals; Body Weight; Corneal Perforation; Diarrhea, Infantile; Disease Models, Animal; Failure to Thrive; Female; Humans; Infant; Infant Formula; Male; Mice; Phenylalanine; Phenylketonurias; Random Allocation; Tyrosine; Vitamin A Deficiency | 2013 |
Vortioxetine, but not escitalopram or duloxetine, reverses memory impairment induced by central 5-HT depletion in rats: evidence for direct 5-HT receptor modulation.
Topics: 5-Hydroxytryptophan; Animals; Carbidopa; Citalopram; Disease Models, Animal; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Exploratory Behavior; Female; Hippocampus; Maze Learning; Memory Disorders; Phenylalanine; Piperazines; Protein Binding; Rats; Rats, Long-Evans; Recognition, Psychology; Selective Serotonin Reuptake Inhibitors; Serotonin; Sulfides; Thiophenes; Vortioxetine | 2014 |
4-Chloro-DL-phenylalanine protects against monocrotaline‑induced pulmonary vascular remodeling and lung inflammation.
Topics: Animals; Disease Models, Animal; Down-Regulation; Familial Primary Pulmonary Hypertension; Fenclonine; Hypertension, Pulmonary; Intercellular Adhesion Molecule-1; Interleukin-1beta; Lung; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Monocrotaline; Phenylalanine; Pneumonia; Rats; Rats, Sprague-Dawley; RNA-Binding Proteins; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Tryptophan Hydroxylase; Tumor Necrosis Factor-alpha | 2014 |
Altered brain protein expression profiles are associated with molecular neurological dysfunction in the PKU mouse model.
Topics: Animals; Biomarkers; Blotting, Western; Brain Chemistry; Chromatography, High Pressure Liquid; Computational Biology; Computer Simulation; Disease Models, Animal; Electrophoresis, Gel, Two-Dimensional; Gene Regulatory Networks; Mice; Nervous System Diseases; Phenylalanine; Phenylketonurias; Protein Biosynthesis; Tandem Mass Spectrometry | 2014 |
Treatment of phenylketonuria using minicircle-based naked-DNA gene transfer to murine liver.
Topics: Animals; Disease Models, Animal; DNA, Superhelical; Female; Genetic Therapy; Genetic Vectors; Liver; Male; Mice, Inbred C57BL; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias; Promoter Regions, Genetic | 2014 |
Dental Anomalies Associated with Craniometaphyseal Dysplasia.
Topics: Acid Phosphatase; Animals; Bone Density; Bone Diseases, Developmental; Cephalometry; Cone-Beam Computed Tomography; Craniofacial Abnormalities; Disease Models, Animal; Gene Knock-In Techniques; Humans; Hyperostosis; Hypertelorism; Isoenzymes; Mandible; Maxilla; Mice; Mutation; Osteoclasts; Phenylalanine; Phosphate Transport Proteins; Sequence Deletion; Skull Base; Tartrate-Resistant Acid Phosphatase; Tooth Abnormalities; Tooth Movement Techniques; Vertical Dimension; X-Ray Microtomography | 2014 |
Vortioxetine restores reversal learning impaired by 5-HT depletion or chronic intermittent cold stress in rats.
Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Attention; Autoradiography; Body Weight; Cold Temperature; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Learning Disabilities; Male; Phenylalanine; Piperazines; Rats; Rats, Sprague-Dawley; Reversal Learning; Serotonin; Stress, Psychological; Sulfides; Vortioxetine | 2014 |
Comparative analysis of pathology and boronophenylalanine uptake in experimental orthotopic and heterotopic amelanotic melanoma.
Topics: Animals; Boron Compounds; Cell Line, Tumor; Disease Models, Animal; Heterografts; Humans; Melanoma, Amelanotic; Mice; Mice, Inbred BALB C; Mice, Nude; Phenylalanine; Skin Neoplasms | 2014 |
Contribution of the nos-pdt operon to virulence phenotypes in methicillin-sensitive Staphylococcus aureus.
Topics: Animals; Carotenoids; Disease Models, Animal; Female; Fluoresceins; Genes, Bacterial; Intracellular Space; Methicillin; Mice; Nitric Oxide; Nitric Oxide Synthase; Operon; Oxidative Stress; Phenotype; Phenylalanine; Pigmentation; Prephenate Dehydratase; Reactive Nitrogen Species; Sepsis; Staphylococcus aureus; Survival Analysis; Transcription, Genetic; Virulence | 2014 |
Hippocampal synaptic connectivity in phenylketonuria.
Topics: Animals; Disease Models, Animal; Gene Expression Regulation; Hippocampus; Humans; Long-Term Potentiation; Mice; Mice, Knockout; Microglia; Neurons; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias; Synapses; Synaptic Transmission; Synaptosomal-Associated Protein 25 | 2015 |
Disturbed flow induces systemic changes in metabolites in mouse plasma: a metabolomics study using ApoE⁻/⁻ mice with partial carotid ligation.
Topics: Animals; Apolipoproteins E; Biomarkers; Carotid Arteries; Carotid Artery Diseases; Carotid Stenosis; Chromatography, Liquid; Disease Models, Animal; Ligation; Male; Mass Spectrometry; Metabolomics; Methionine; Mice, Knockout; Phenylalanine; Phosphatidylcholines; Phosphatidylethanolamines; Regional Blood Flow; Sphingomyelins; Time Factors | 2015 |
Inhibition of matrix metalloproteinases attenuates brain damage in experimental meningococcal meningitis.
Topics: Animals; Apoptosis; Blood-Brain Barrier; Cerebellum; Cerebral Hemorrhage; Chemokines; Cytokines; Dentate Gyrus; Disease Models, Animal; Female; Kaplan-Meier Estimate; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Meningitis, Meningococcal; Mice; Phenylalanine; Thiophenes | 2014 |
Deletion of Stat3 in hematopoietic cells enhances thrombocytosis and shortens survival in a JAK2-V617F mouse model of MPN.
Topics: Amino Acid Substitution; Animals; Bone Marrow; Bone Marrow Neoplasms; Disease Models, Animal; Disease Progression; Gene Deletion; Hematopoietic Stem Cells; Janus Kinase 2; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myeloproliferative Disorders; Phenylalanine; STAT3 Transcription Factor; Thrombocytosis; Valine | 2015 |
The Anti-Proliferative Effect of Boron Neutron Capture Therapy in a Prostate Cancer Xenograft Model.
Topics: Animals; Apoptosis; Boron Compounds; Boron Neutron Capture Therapy; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Radiation; Humans; Male; Mice; Mice, Nude; Neutrons; Phenylalanine; Prostatic Neoplasms; Xenograft Model Antitumor Assays | 2015 |
Quantitative analysis of phenylalanine, tyrosine, tryptophan and kynurenine in rat model for tauopathies by ultra-high performance liquid chromatography with fluorescence and mass spectrometry detection.
Topics: Animals; Chromatography, High Pressure Liquid; Disease Models, Animal; Humans; Kynurenine; Phenylalanine; Rats; Rats, Inbred SHR; Rats, Transgenic; Tandem Mass Spectrometry; Tauopathies; Tryptophan; Tyrosine | 2016 |
Improvement of Outcome Measures of Dry Eye by a Novel Integrin Antagonist in the Murine Desiccating Stress Model.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Biomarkers; Cell Adhesion; Cells, Cultured; Cornea; Dendritic Cells; Disease Models, Animal; Dry Eye Syndromes; Female; Flow Cytometry; Integrin alpha Chains; Integrin alpha4; Integrin alpha4beta1; Leukocytes; Mice; Mice, Inbred C57BL; Organic Chemicals; Phenylalanine; Piperidines; Vascular Cell Adhesion Molecule-1 | 2015 |
Prevention of abdominal aortic aneurysm progression by targeted inhibition of matrix metalloproteinase activity with batimastat-loaded nanoparticles.
Topics: Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Calcium Chloride; Chemistry, Pharmaceutical; Disease Models, Animal; Disease Progression; Drug Carriers; Elastin; Immunoconjugates; Macrophages; Male; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Mice; Nanoparticles; Phenylalanine; Polyesters; Proteolysis; Rats, Sprague-Dawley; RAW 264.7 Cells; Thiophenes; Time Factors; Vascular Calcification | 2015 |
Sjögren's syndrome associated dry eye in a mouse model is ameliorated by topical application of integrin α4 antagonist GW559090.
Topics: Administration, Topical; Animals; Cell Count; Dexamethasone; Disease Models, Animal; Dry Eye Syndromes; Fluorescein; Glucocorticoids; Goblet Cells; Integrin alpha4beta1; Interleukin-1beta; Mice; Mice, Inbred C57BL; Nuclear Receptor Subfamily 1, Group F, Member 3; Ophthalmic Solutions; Phenylalanine; Piperidines; Real-Time Polymerase Chain Reaction; RNA, Messenger; Sjogren's Syndrome; Staining and Labeling; Thrombospondin 1 | 2016 |
Large Neutral Amino Acid Supplementation Exerts Its Effect through Three Synergistic Mechanisms: Proof of Principle in Phenylketonuria Mice.
Topics: Amino Acids, Neutral; Animals; Brain; Dietary Supplements; Disease Models, Animal; Dopamine; Female; Male; Mice; Neurocognitive Disorders; Phenylalanine; Phenylketonurias; Serotonin | 2015 |
High dose sapropterin dihydrochloride therapy improves monoamine neurotransmitter turnover in murine phenylketonuria (PKU).
Topics: Administration, Oral; Animals; Biopterins; Brain; Disease Models, Animal; Dopamine; Genotype; Homovanillic Acid; Humans; Indoles; Mice; Neurotransmitter Agents; Phenylalanine; Phenylketonurias; Serotonin; Tryptophan Hydroxylase; Tyrosine 3-Monooxygenase | 2016 |
DNA methylation in the pathophysiology of hyperphenylalaninemia in the PAH(enu2) mouse model of phenylketonuria.
Topics: Animals; Brain; Calcium-Binding Proteins; Disease Models, Animal; DNA Methylation; Gene Expression Regulation; Genomic Imprinting; Humans; Intercellular Signaling Peptides and Proteins; Iodide Peroxidase; Liver; Mice; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias; Promoter Regions, Genetic; RNA, Untranslated | 2016 |
Phenylketonuria: Direct and indirect effects of phenylalanine.
Topics: Animals; Cells, Cultured; Cofilin 1; Dendrites; Disease Models, Animal; Embryo, Mammalian; Entorhinal Cortex; Excitatory Amino Acid Agonists; Gene Expression Regulation; Hippocampus; In Vitro Techniques; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microglia; Mutation; N-Methylaspartate; Neurons; Phagocytosis; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias; rac1 GTP-Binding Protein; Synapses | 2016 |
A novel small molecule ameliorates ocular neovascularisation and synergises with anti-VEGF therapy.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Neutralizing; Biological Assay; Choroid; Choroidal Neovascularization; Chromones; Disease Models, Animal; Drug Combinations; Drug Synergism; Female; Gene Expression; Humans; Intravitreal Injections; Larva; Mice; Mice, Inbred C57BL; Phenylalanine; Retina; Tissue Culture Techniques; Vascular Endothelial Growth Factor A; Zebrafish | 2016 |
Effects of DA-Phen, a dopamine-aminoacidic conjugate, on alcohol intake and forced abstinence.
Topics: Alcohol Deterrents; Alcohol Drinking; Alcoholism; Animals; Anxiety; Central Nervous System Depressants; Conditioning, Operant; Disease Models, Animal; Dopamine; Dopamine Agents; Drug-Seeking Behavior; Ethanol; Male; Phenylalanine; Rats, Wistar; Recurrence; Self Administration | 2016 |
Drug development: A healthy pipeline.
Topics: Animals; Benzimidazoles; Benzofurans; Bile Acids and Salts; Carbolines; Colesevelam Hydrochloride; Colestipol; Disease Models, Animal; Enteric Nervous System; Female; Humans; Imidazoles; Indoles; Irritable Bowel Syndrome; Loperamide; Lubiprostone; Male; Mice; Natriuretic Peptides; Peptides; Phenylalanine; Receptors, Serotonin, 5-HT3; Receptors, Serotonin, 5-HT4; Rifamycins; Rifaximin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Visceral Pain | 2016 |
Tetrahydrobiopterin Supplementation Improves Phenylalanine Metabolism in a Murine Model of Severe Malaria.
Topics: Animals; Aorta; Arginine; Biopterins; Brain; Disease Models, Animal; Humans; Malaria; Mice; Mice, Inbred C57BL; Nitric Oxide; Phenylalanine; Plasmodium berghei | 2016 |
Therapeutic brain modulation with targeted large neutral amino acid supplements in the Pah-enu2 phenylketonuria mouse model.
Topics: Amino Acids, Neutral; Animals; Brain; Diet; Dietary Supplements; Disease Models, Animal; Dopamine; Female; Male; Mice; Mice, Knockout; Neurotransmitter Agents; Phenylalanine; Phenylketonurias; Serotonin | 2016 |
DCoH: A novel biomarker for diagnosing acute kidney injury.
Topics: Acute Kidney Injury; Animals; Biomarkers; Cell Line; Disease Models, Animal; Disease Progression; Gene Expression Regulation; Humans; Hydro-Lyases; Models, Theoretical; Phenylalanine; Prognosis | 2016 |
Multicompartment analysis of protein-restricted phenylketonuric mice reveals amino acid imbalances in brain.
Topics: Amino Acids; Animals; Brain; Diet, Protein-Restricted; Disease Models, Animal; Mice; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias | 2017 |
Chondroprotective activity of N-acetyl phenylalanine glucosamine derivative on knee joint structure and inflammation in a murine model of osteoarthritis.
Topics: ADAMTS5 Protein; Animals; Cartilage, Articular; Disease Models, Animal; Glucosamine; I-kappa B Kinase; Inflammation; Injections, Intra-Articular; Knee Joint; Male; Matrix Metalloproteinase 10; Matrix Metalloproteinase 13; Menisci, Tibial; Mice; Organ Size; Osteoarthritis, Knee; Phenylalanine | 2017 |
CCL11 promotes migration and proliferation of mouse neural progenitor cells.
Topics: Animals; Animals, Newborn; Benzamides; Brain; Brain Injuries; Carotid Arteries; Cell Movement; Cell Proliferation; Cerebrovascular Disorders; Chemokine CCL11; Chemokines, CC; Disease Models, Animal; Hypoxia-Ischemia, Brain; Mice; Mice, Inbred NOD; Mice, SCID; Neural Stem Cells; Phenylalanine; Primary Cell Culture; Receptors, CCR3 | 2017 |
Parachlorophenylalanine-induced 5-HT depletion alters behavioral and brain neurotransmitters levels in 6-Hz psychomotor seizure model in mice.
Topics: Animals; Brain; Disease Models, Animal; Electroshock; gamma-Aminobutyric Acid; Glutamine; Male; Mice; Neurotransmitter Agents; Phenylalanine; Psychomotor Agitation; Seizures; Serotonin; Valproic Acid | 2017 |
miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesis.
Topics: Animals; Ataxin-1; Ataxins; Cell Line, Transformed; Cerebellum; Disease Models, Animal; Gene Expression Regulation; Glutamine; Green Fluorescent Proteins; Humans; Mice; Mice, Transgenic; MicroRNAs; Nerve Tissue Proteins; Nuclear Proteins; Phenylalanine; Purkinje Cells; RNA, Small Interfering; Spinocerebellar Ataxias; Time Factors; Transfection; Trinucleotide Repeat Expansion | 2008 |
The pro-nociceptive effects of remifentanil or surgical injury in mice are associated with a decrease in delta-opioid receptor mRNA levels: Prevention of the nociceptive response by on-site delivery of enkephalins.
Topics: Analgesics; Animals; Disease Models, Animal; Disulfides; Down-Regulation; Enkephalins; Ganglia, Spinal; Male; Methyl Ethers; Mice; Pain Measurement; Pain Threshold; Pain, Postoperative; Phenylalanine; Piperidines; Protein Precursors; Receptors, Opioid, delta; Receptors, Opioid, mu; Remifentanil; RNA, Messenger; Sevoflurane; Spinal Cord; Time Factors | 2009 |
TIMP-3 and MMP-3 contribute to delayed inflammation and hippocampal neuronal death following global ischemia.
Topics: ADAM Proteins; ADAM17 Protein; Animals; Apoptosis; Brain Ischemia; Disease Models, Animal; Encephalitis; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Gliosis; Hippocampus; Matrix Metalloproteinase 3; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred C57BL; Mice, Knockout; Nerve Degeneration; Neuroprotective Agents; Phenylalanine; Receptors, Tumor Necrosis Factor, Type I; Reperfusion Injury; Thiophenes; Tissue Inhibitor of Metalloproteinase-3; Tumor Necrosis Factor-alpha | 2009 |
Insight into the mechanisms underlying tumor response to boron neutron capture therapy in the hamster cheek pouch oral cancer model.
Topics: Animals; Apoptosis; Boron Compounds; Boron Neutron Capture Therapy; Cheek; Cricetinae; Disease Models, Animal; DNA, Neoplasm; Drug Carriers; In Situ Nick-End Labeling; Mesocricetus; Mouth Neoplasms; Neoplasms, Experimental; Phenylalanine; Radiation Dosage; Radiation-Sensitizing Agents; Radiopharmaceuticals | 2009 |
Pharmacokinetics of nateglinide enantiomers and their metabolites in Goto-Kakizaki rats, a model for type 2 diabetes mellitus.
Topics: Animals; Cyclohexanes; Diabetes Mellitus, Type 2; Disease Models, Animal; Hypoglycemic Agents; Male; Nateglinide; Phenylalanine; Rats; Rats, Wistar; Stereoisomerism | 2010 |
Feasibility study on the utilization of boron neutron capture therapy (BNCT) in a rat model of diffuse lung metastases.
Topics: Animals; Boron Compounds; Boron Neutron Capture Therapy; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Disease Models, Animal; In Vitro Techniques; Lung Neoplasms; Phenylalanine; Radiation Tolerance; Radiation-Sensitizing Agents; Rats | 2009 |
5-Hydroxytryptophan rescues serotonin response to stress in prefrontal cortex of hyperphenylalaninaemic mice.
Topics: 5-Hydroxytryptophan; Analysis of Variance; Animals; Antidepressive Agents, Second-Generation; Diet, Reducing; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Mice; Microdialysis; Neuraminidase; Norepinephrine; Phenylalanine; Phenylketonurias; Prefrontal Cortex; Serotonin; Time Factors; Tryptophan Hydroxylase | 2009 |
Mechanisms of toxic smoke inhalation and burn injury: role of neutral endopeptidase and vascular leakage in mice.
Topics: Animals; Burns; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Neprilysin; Organophosphonates; Phenylalanine; Protease Inhibitors; Pulmonary Edema; Smoke Inhalation Injury | 2009 |
Divergent role for MMP-2 in myelin breakdown and oligodendrocyte death following transient global ischemia.
Topics: Animals; Caspase 3; Cell Death; Disease Models, Animal; Enzyme Inhibitors; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Ischemic Attack, Transient; Matrix Metalloproteinase 2; Mice; Mice, Inbred C57BL; Myelin Basic Protein; Myelin Sheath; Oligodendroglia; Phenylalanine; Thiophenes; Time Factors | 2010 |
Involvement of NMDAR2A tyrosine phosphorylation in depression-related behaviour.
Topics: Animals; Cell Line; Depression; Disease Models, Animal; Down-Regulation; Gene Knock-In Techniques; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Phenylalanine; Phosphorylation; Receptors, N-Methyl-D-Aspartate; Signal Transduction; Tyrosine | 2009 |
Tissue-specific activation of mitogen-activated protein kinases for expression of transthyretin by phenylalanine and its metabolite, phenylpyruvic acid.
Topics: Animals; Brain Stem; Disease Models, Animal; Gene Expression Regulation; Hep G2 Cells; Hepatocyte Nuclear Factor 4; Humans; Liver; Mice; Mice, Mutant Strains; Mitogen-Activated Protein Kinase 3; Organ Specificity; p38 Mitogen-Activated Protein Kinases; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias; Phenylpyruvic Acids; Prealbumin | 2010 |
Efficacy of 3,5-dibromo-L-phenylalanine in rat models of stroke, seizures and sensorimotor gating deficit.
Topics: Animals; Disease Models, Animal; Dizocilpine Maleate; Endothelin-1; Gait Disorders, Neurologic; Glutamic Acid; Male; Pentylenetetrazole; Phenylalanine; Rats; Rats, Sprague-Dawley; Reflex, Startle; Seizures; Stroke | 2009 |
MMP-7 mediates cleavage of N-cadherin and promotes smooth muscle cell apoptosis.
Topics: Animals; Antigens, CD; Apolipoproteins E; Apoptosis; Atherosclerosis; Cadherins; Caspase 3; Cells, Cultured; Disease Models, Animal; Fas Ligand Protein; Humans; Matrix Metalloproteinase 7; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phenylalanine; Protease Inhibitors; Recombinant Proteins; Rupture; Thiophenes; Time Factors | 2010 |
Oligodendrocyte development and myelinogenesis are not impaired by high concentrations of phenylalanine or its metabolites.
Topics: Animals; Cells, Cultured; Corpus Callosum; Disease Models, Animal; Lac Operon; Mice; Mice, Mutant Strains; Mice, Transgenic; Myelin Basic Protein; Myelin Sheath; Oligodendroglia; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias; Promoter Regions, Genetic; Rats; Rats, Wistar | 2010 |
Pahenu1 is a mouse model for tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency and promotes analysis of the pharmacological chaperone mechanism in vivo.
Topics: Amino Acid Substitution; Animals; Biopterins; Chlorocebus aethiops; COS Cells; Disease Models, Animal; Humans; Hydroxylation; Kinetics; Mice; Molecular Chaperones; Mutation; Phenylalanine; Phenylalanine Hydroxylase; Protein Folding; Protein Processing, Post-Translational; Protein Structure, Quaternary | 2010 |
[Protective role of MMP-9 inhibitor batimastat in acute lung injury after cardiopulmonary bypass].
Topics: Acute Lung Injury; Animals; Cardiopulmonary Bypass; Disease Models, Animal; Dogs; Lung; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Phenylalanine; Postoperative Complications; Thiophenes | 2010 |
Matrix metalloproteinase inhibitor batimastat alleviates pathology and improves skeletal muscle function in dystrophin-deficient mdx mice.
Topics: Animals; Disease Models, Animal; Dystrophin; Fibrosis; Gene Expression Regulation; Humans; Inflammation; Male; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Mitogen-Activated Protein Kinases; Molecular Sequence Data; Muscle, Skeletal; Muscular Dystrophy, Duchenne; Phenylalanine; Protease Inhibitors; Thiophenes; Transcription Factor AP-1 | 2010 |
New insights into tetrahydrobiopterin pharmacodynamics from Pah enu1/2, a mouse model for compound heterozygous tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency.
Topics: Animals; Biopterins; Breath Tests; Disease Models, Animal; Dose-Response Relationship, Drug; Heterozygote; Mice; Mice, Mutant Strains; Mutation; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias; Treatment Outcome; Tyrosine | 2010 |
A novel strategy for development of glucocorticoids through non-genomic mechanism.
Topics: Animals; Cell Line; Disease Models, Animal; Genome; Glucocorticoids; Guinea Pigs; Histamine; Humans; Hydrocortisone; Male; Mast Cells; Molecular Structure; Neutrophils; Peroxidase; Phenylalanine; Rats; Time Factors | 2011 |
Combination therapy with nateglinide and telmisartan ameliorates insulin resistance in zucker Fatty rats by suppressing advanced glycation end product receptor axis.
Topics: Animals; Benzimidazoles; Benzoates; Cyclohexanes; Disease Models, Animal; Down-Regulation; Drug Therapy, Combination; Glycation End Products, Advanced; Humans; Insulin Resistance; Liver; Male; Nateglinide; Phenylalanine; Rats; Rats, Zucker; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Telmisartan | 2011 |
Boron uptake measurements in a rat model for Boron Neutron Capture Therapy of lung tumours.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Boron; Boron Compounds; Boron Neutron Capture Therapy; Disease Models, Animal; Lung Neoplasms; Phenylalanine; Rats | 2011 |
CCR3 and choroidal neovascularization.
Topics: Animals; Antibodies, Neutralizing; Choroidal Neovascularization; Collagen; Disease Models, Animal; Drug Combinations; Laminin; Mice; Mice, Inbred BALB C; Models, Biological; Molecular Targeted Therapy; Naphthalenes; Phenylalanine; Proteoglycans; Rats; Rats, Sprague-Dawley; Receptors, CCR3; TOR Serine-Threonine Kinases; Vascular Endothelial Growth Factor A | 2011 |
Validation of an amino-acid-based radionuclide therapy plus external beam radiotherapy in heterotopic glioblastoma models.
Topics: Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Disease Models, Animal; Glioblastoma; Humans; Iodine Radioisotopes; Mice; Phenylalanine; Radiotherapy; Rats; Transplantation, Heterotopic | 2011 |
Partial impairment of c-Ret at tyrosine 1062 accelerates age-related hearing loss in mice.
Topics: Animals; Disease Models, Animal; Genetic Carrier Screening; Mice; Mice, Inbred C57BL; Mice, Neurologic Mutants; Mutation; Phenylalanine; Phosphorylation; Presbycusis; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-ret; Spiral Ganglion; Tyrosine; Up-Regulation | 2012 |
UPLC-MS-based urine metabolomics reveals indole-3-lactic acid and phenyllactic acid as conserved biomarkers for alcohol-induced liver disease in the Ppara-null mouse model.
Topics: Alcohols; Analysis of Variance; Animals; Biomarkers; Chromatography, High Pressure Liquid; Disease Models, Animal; Indoles; Lactates; Liver Diseases, Alcoholic; Male; Mass Spectrometry; Metabolic Networks and Pathways; Metabolomics; Mice; Mice, Knockout; Phenylalanine; PPAR alpha; Principal Component Analysis; Taurine; Tryptophan | 2011 |
Boron Neutron Capture Therapy (BNCT) in an oral precancer model: therapeutic benefits and potential toxicity of a double application of BNCT with a six-week interval.
Topics: Animals; Boron Compounds; Boron Neutron Capture Therapy; Cheek; Cricetinae; Disease Models, Animal; DNA; Mouth Neoplasms; Mucositis; Phenylalanine; Precancerous Conditions; Radiation Injuries, Experimental; Treatment Outcome | 2011 |
Regular exercise prevents oxidative stress in the brain of hyperphenylalaninemic rats.
Topics: Animals; Antioxidants; Brain Chemistry; Catalase; Disease Models, Animal; Glutathione Peroxidase; Glycogen; Muscle, Skeletal; Oxidative Stress; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias; Physical Conditioning, Animal; Rats; Rats, Wistar; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances | 2011 |
Pyrolo[1,2:4,5]-1,4-dioxopyrazino[1,2:1,6]pyrido[3,4-b]indoles: a group of urokinase inhibitors, their synthesis, and stereochemistry-dependent activity.
Topics: Animals; Antifibrinolytic Agents; Blood Proteins; Disease Models, Animal; Enzyme Activation; Heterocyclic Compounds, 4 or More Rings; Indoles; Male; Mice; Mice, Inbred ICR; Phenylalanine; Rats; Rats, Wistar; Stereoisomerism; Thrombosis; Urokinase-Type Plasminogen Activator | 2011 |
Tumor blood vessel "normalization" improves the therapeutic efficacy of boron neutron capture therapy (BNCT) in experimental oral cancer.
Topics: Angiogenesis Inhibitors; Animals; Blood Vessels; Boron Compounds; Boron Neutron Capture Therapy; Cheek; Cricetinae; Disease Models, Animal; Dose-Response Relationship, Radiation; Mouth Neoplasms; Phenylalanine; Thalidomide; Treatment Outcome | 2012 |
Recovery of neurogenic amines in phenylketonuria mice after liver-targeted gene therapy.
Topics: Animals; Brain; Catecholamines; Disease Models, Animal; Gene Transfer Techniques; Genetic Therapy; Liver; Mice; Mice, Transgenic; Neurotransmitter Agents; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias; Serotonin | 2012 |
Metabonomic study on the anti-osteoporosis effect of Rhizoma Drynariae and its action mechanism using ultra-performance liquid chromatography-tandem mass spectrometry.
Topics: Alkaline Phosphatase; Animals; Biomarkers; Bone Density; Bone Density Conservation Agents; Chromatography, Liquid; Disease Models, Animal; Drugs, Chinese Herbal; Femur; Lysophosphatidylcholines; Metabolomics; Osteocalcin; Osteoporosis; Phenylalanine; Polypodiaceae; Prednisolone; Protein Carbonylation; Rats; Rats, Wistar; Rhizome; Tandem Mass Spectrometry; Tibia; Tryptophan | 2012 |
Critical requirement for Stat5 in a mouse model of polycythemia vera.
Topics: Amino Acid Substitution; Animals; Disease Models, Animal; Gene Knock-In Techniques; Genes, Lethal; HEK293 Cells; Humans; Janus Kinase 2; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation, Missense; Phenylalanine; Polycythemia Vera; STAT5 Transcription Factor; Valine | 2012 |
A new mouse model for the slow-channel congenital myasthenic syndrome induced by the AChR εL221F mutation.
Topics: Acetylcholinesterase; Aminophenols; Animals; Biophysics; Diaphragm; Disease Models, Animal; Gene Expression Regulation; Genetic Predisposition to Disease; Hand Strength; Humans; In Vitro Techniques; Isoleucine; Mice; Mice, Transgenic; Microscopy, Electron, Transmission; Miniature Postsynaptic Potentials; Motor Endplate; Mutagenesis; Myasthenic Syndromes, Congenital; Neurofilament Proteins; Neuromuscular Junction; Patch-Clamp Techniques; Phenylalanine; Receptors, Nicotinic; S100 Proteins; Synaptophysin; Time Factors | 2012 |
What is the role of CCR3 in choroidal neovascularization?
Topics: Animals; Antibodies, Neutralizing; Biocompatible Materials; Choroidal Neovascularization; Collagen; Disease Models, Animal; Drug Combinations; Laminin; Macular Degeneration; Mice; Mice, Inbred BALB C; Naphthalenes; Phenylalanine; Proteoglycans; Rats; Rats, Sprague-Dawley; Receptors, CCR3 | 2012 |
Metabolic differences underlying two distinct rat urinary phenotypes, a suggested role for gut microbial metabolism of phenylalanine and a possible connection to autism.
Topics: Animals; Autistic Disorder; Bacterial Proteins; Biomarkers; Chlorogenic Acid; Clostridium; Disease Models, Animal; Fungal Proteins; Glycine; Hippurates; Humans; Intestines; Phenylalanine; Phenylalanine Ammonia-Lyase; Rats; Stereoisomerism; Systems Biology; Tryptophan; Tyrosine; Yeasts | 2012 |
Reversal of metabolic and neurological symptoms of phenylketonuric mice treated with a PAH containing helper-dependent adenoviral vector.
Topics: Adenoviridae; Animals; Disease Models, Animal; Electrophysiology; Genetic Therapy; Genetic Vectors; Humans; Learning Disabilities; Mice; N-Methylaspartate; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias; Pigmentation; Tyrosine | 2012 |
The mechanism of BH4 -responsive hyperphenylalaninemia--as it occurs in the ENU1/2 genetic mouse model.
Topics: Animals; Biopterins; Disease Models, Animal; Female; Hydroxylation; Male; Mice; Mice, Mutant Strains; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias | 2012 |
Cure of hookworm infection with a cysteine protease inhibitor.
Topics: Administration, Oral; Ancylostoma; Animals; Anthelmintics; Cricetinae; Cysteine Proteinase Inhibitors; Dipeptides; Disease Models, Animal; Female; Hookworm Infections; Larva; Male; Mesocricetus; Phenylalanine; Piperazines; Sulfones; Survival Analysis; Tosyl Compounds; Treatment Outcome; Vinyl Compounds; Zygote | 2012 |
Cardiac teratogenicity in mouse maternal phenylketonuria: defining phenotype parameters and genetic background influences.
Topics: Abnormalities, Multiple; Animals; Disease Models, Animal; Female; Genetic Association Studies; Heart Defects, Congenital; Heart Valves; Humans; Male; Mice; Mice, Transgenic; Phenotype; Phenylalanine; Phenylketonuria, Maternal; Pregnancy | 2012 |
A highly selective and potent PTP-MEG2 inhibitor with therapeutic potential for type 2 diabetes.
Topics: Animals; Diabetes Mellitus, Type 2; Disease Models, Animal; Mice; Mice, Inbred C57BL; Mice, Obese; Models, Molecular; Molecular Structure; Phenylalanine; Protein Tyrosine Phosphatases, Non-Receptor | 2012 |
Corneal inflammation is inhibited by the LFA-1 antagonist, lifitegrast (SAR 1118).
Topics: Animals; CD11a Antigen; CD18 Antigens; Contact Lenses; Cornea; Corneal Stroma; Disease Models, Animal; Eye Infections, Bacterial; Inflammation; Lymphocyte Function-Associated Antigen-1; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Confocal; Neutrophil Infiltration; Phenylalanine; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Sulfones | 2013 |
Role of catalase and superoxide dismutase activities on oxidative stress in the brain of a phenylketonuria animal model and the effect of lipoic acid.
Topics: Animals; Brain; Catalase; Disease Models, Animal; DNA Damage; Enzyme Inhibitors; Female; Lipid Peroxidation; Male; Oxidative Stress; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias; Rats; Rats, Wistar; Superoxide Dismutase; Thioctic Acid | 2013 |
RNA splicing and editing modulation of 5-HT(2C) receptor function: relevance to anxiety and aggression in VGV mice.
Topics: Aggression; Animals; Anxiety; Bioluminescence Resonance Energy Transfer Techniques; Brain; Defense Mechanisms; Disease Models, Animal; Gene Expression Regulation; Glycine; HEK293 Cells; Humans; Hydroxyindoleacetic Acid; Interpersonal Relations; Mice; Mice, Inbred C57BL; Mutation; Phenylalanine; Protein Binding; Protein Isoforms; Receptor, Serotonin, 5-HT2C; RNA Editing; RNA Precursors; RNA Splicing; RNA, Messenger; Transfection; Ultrasonics; Valine | 2013 |
The phenylketonuria mouse model: a meeting review.
Topics: Animals; Disease Models, Animal; Genetic Therapy; Mice; Neurochemistry; Phenylalanine; Phenylketonurias | 2002 |
Oxidative stress induced by phenylketonuria in the rat: Prevention by melatonin, vitamin E, and vitamin C.
Topics: Animals; Animals, Newborn; Antioxidants; Ascorbic Acid; Brain; Cerebellum; Disease Models, Animal; Female; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Humans; Lipid Peroxidation; Melatonin; Nervous System Malformations; Neurons; Oxidative Stress; Phenylalanine; Phenylketonurias; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Vitamin E | 2002 |
Elevated plasma phenylalanine concentrations may adversely affect bone status of phenylketonuric mice.
Topics: Animals; Biomarkers; Bone Density; Bone Resorption; Diet; Disease Models, Animal; Femoral Fractures; Femur; Fractures, Bone; Male; Mice; Organ Size; Osteocalcin; Phenylalanine; Phenylketonurias; Weight Gain | 2002 |
MMP inhibition and the development of cerebrovascular atherosclerosis: The road ahead.
Topics: Animals; Brain; Cerebrovascular Circulation; Disease Models, Animal; Enzyme Inhibitors; Extracellular Matrix; Female; Glycine; Hemodynamics; Humans; Hydroxamic Acids; Infarction, Middle Cerebral Artery; Intracranial Arteriosclerosis; Male; Matrix Metalloproteinase 1; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Mice; Phenylalanine; Thiophenes; Treatment Outcome | 2002 |
Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation.
Topics: Adipocytes; Animals; Blood Vessels; CCAAT-Enhancer-Binding Protein-beta; Cell Differentiation; Diet; Disease Models, Animal; Gene Expression Regulation, Enzymologic; Hypoglycemic Agents; Male; Matrix Metalloproteinase 12; Matrix Metalloproteinase 2; Matrix Metalloproteinase 3; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Matrix Metalloproteinases, Membrane-Associated; Matrix Metalloproteinases, Secreted; Metalloendopeptidases; Mice; Mice, Inbred AKR; Mice, Inbred C57BL; Mice, Obese; Mitosis; Obesity; Phenylalanine; Protease Inhibitors; RNA, Messenger; Rosiglitazone; Stromal Cells; Thiazoles; Thiazolidinediones; Thiophenes; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-3 | 2003 |
Evaluation of vascular endothelial growth factor blockade and matrix metalloproteinase inhibition as a combination therapy for experimental human pancreatic cancer.
Topics: Angiogenesis Inhibitors; Animals; Animals, Newborn; Chi-Square Distribution; Disease Models, Animal; Drug Therapy, Combination; Endothelial Growth Factors; Humans; Intercellular Signaling Peptides and Proteins; Lymphokines; Male; Matrix Metalloproteinases; Mice; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Pancreatic Neoplasms; Phenylalanine; Probability; Reference Values; Sensitivity and Specificity; Statistics, Nonparametric; Thiophenes; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2003 |
Calpain inhibitor (BSF 409425) diminishes ischemia/reperfusion-induced damage of rabbit heart mitochondria.
Topics: Animals; Calpain; Disease Models, Animal; Enzyme Inhibitors; In Vitro Techniques; Mitochondria, Heart; Phenylalanine; Rabbits; Reperfusion Injury | 2003 |
The behavioral profile of severe mental retardation in a genetic mouse model of phenylketonuria.
Topics: Animals; Disease Models, Animal; Emotions; Exploratory Behavior; Genotype; Heterozygote; Homozygote; Humans; Intellectual Disability; Maze Learning; Mice; Mice, Inbred Strains; Phenylalanine; Phenylketonurias; Space Perception | 2003 |
Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion.
Topics: Animals; Blood-Brain Barrier; Brain; Brain Ischemia; Disease Models, Animal; Drug Administration Schedule; Enzyme Inhibitors; Infarction, Middle Cerebral Artery; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Phenylalanine; Rats; Rats, Wistar; Recombinant Proteins; Reperfusion; Sucrose; Survival Rate; Thiophenes; Time Factors; Tissue Plasminogen Activator; Treatment Outcome; Water | 2003 |
Relationship between myelin production and dopamine synthesis in the PKU mouse brain.
Topics: Animals; Blotting, Western; Brain; Brain Chemistry; Corpus Striatum; Disease Models, Animal; Dopamine; Food, Formulated; Frontal Lobe; Male; Mice; Mice, Mutant Strains; Myelin Basic Protein; Myelin Sheath; Neurofilament Proteins; Phenylalanine; Phenylketonurias; Phosphorylation; Tyrosine; Tyrosine 3-Monooxygenase | 2003 |
Future role of large neutral amino acids in transport of phenylalanine into the brain.
Topics: Amino Acids, Neutral; Animals; Biological Transport; Blood-Brain Barrier; Brain; Disease Models, Animal; Energy Metabolism; Mice; Mice, Mutant Strains; Phenylalanine; Phenylketonurias | 2003 |
Analysis of boron-10 in soft tissue by dynamic secondary ion mass spectrometry.
Topics: Animals; Boron Compounds; Boron Neutron Capture Therapy; Brain; Brain Neoplasms; Disease Models, Animal; Glioblastoma; Gliosarcoma; Humans; Isotopes; Mice; Phenylalanine; Rats; Spectrometry, Mass, Secondary Ion; Tumor Cells, Cultured | 2004 |
Role of matrix metalloproteinases in delayed neuronal damage after transient global cerebral ischemia.
Topics: Animals; Dipeptides; Disease Models, Animal; Disease Progression; Hippocampus; Immunohistochemistry; Ischemic Attack, Transient; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Mice; Mice, Knockout; Neurons; Neuroprotective Agents; Phenylalanine; Protease Inhibitors; Thiophenes | 2004 |
Aza-bicyclic amino acid sulfonamides as alpha(4)beta(1)/alpha(4)beta(7) integrin antagonists.
Topics: Amino Acids; Animals; Antibodies, Monoclonal; Antigens, Helminth; Ascaris; Asthma; Aza Compounds; Bronchi; Disease Models, Animal; Hypersensitivity; Integrin alpha4beta1; Integrins; Molecular Conformation; Molecular Structure; Phenylalanine; Sheep; Structure-Activity Relationship; Sulfonamides | 2004 |
Comparison of voglibose and nateglinide for their acute effects on insulin secretion and free fatty acid levels in OLETF rat portal blood after sucrose loading.
Topics: Animals; Area Under Curve; Blood Glucose; Cyclohexanes; Diabetes Mellitus, Type 2; Disease Models, Animal; Enzyme Inhibitors; Fatty Acids, Nonesterified; Hypoglycemic Agents; Inositol; Insulin; Insulin Secretion; Male; Nateglinide; Phenylalanine; Portal Vein; Postprandial Period; Rats; Rats, Inbred OLETF; Secretory Rate; Sucrose | 2004 |
Neuroprotective action of halogenated derivatives of L-phenylalanine.
Topics: Animals; Disease Models, Animal; In Vitro Techniques; Infarction, Middle Cerebral Artery; L-Lactate Dehydrogenase; Male; Neurons; Neuroprotective Agents; Patch-Clamp Techniques; Phenylalanine; Rats; Rats, Sprague-Dawley; Receptors, Glutamate; Stroke; Synaptic Transmission; Tyrosine | 2004 |
Plasma phenylalanine concentrations are associated with hepatic iron content in a murine model for phenylketonuria.
Topics: Animals; Copper; Dietary Proteins; Disease Models, Animal; Feces; Intestinal Mucosa; Intestines; Iron; Liver; Male; Mice; Organ Size; Phenylalanine; Phenylketonurias; Zinc | 2004 |
Tetrahydrobiopterin deficiency and dopamine loss in a genetic mouse model of Lesch-Nyhan disease.
Topics: Animals; Biopterins; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Agents; Hypoxanthine Phosphoribosyltransferase; Lesch-Nyhan Syndrome; Levodopa; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Phenylalanine; Tyrosine | 2004 |
A new mouse model of type 2 diabetes, produced by N-ethyl-nitrosourea mutagenesis, is the result of a missense mutation in the glucokinase gene.
Topics: Adenine; Amino Acid Sequence; Amino Acid Substitution; Animals; Chromosome Mapping; Diabetes Mellitus, Type 2; Disease Models, Animal; Ethylnitrosourea; Glucokinase; Glucose; Glucose Intolerance; Heterozygote; Homozygote; Isoleucine; Male; Mice; Mice, Mutant Strains; Molecular Sequence Data; Mutagens; Mutation, Missense; Phenylalanine; Phosphorylation; Thymine | 2004 |
Pharmacologic preconditioning of JTE-607, a novel cytokine inhibitor, attenuates ischemia-reperfusion injury in the myocardium.
Topics: Animals; Cytokines; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Myocardial Reperfusion; Myocardial Reperfusion Injury; Phenylalanine; Piperazines; Probability; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity; Survival Rate | 2004 |
Long-term enzymatic and phenotypic correction in the phenylketonuria mouse model by adeno-associated virus vector-mediated gene transfer.
Topics: Animals; Cell Line; Dependovirus; Diet Therapy; Disease Models, Animal; Female; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; Hair Color; Humans; Liver; Male; Mice; Mice, Knockout; Phenotype; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias | 2004 |
Long-term changes in glutamatergic synaptic transmission in phenylketonuria.
Topics: Animals; Blotting, Western; Brain; Cells, Cultured; Chromatography, Liquid; Disease Models, Animal; Humans; Mass Spectrometry; Mice; Patch-Clamp Techniques; Phenylalanine; Phenylketonurias; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission | 2005 |
Radioiodinated phenylalanine derivatives to image pancreatic cancer: a comparative study with [18F]fluoro-2-deoxy-D-glucose in human pancreatic carcinoma xenografts and in inflammation models.
Topics: Adenocarcinoma; Animals; Cell Line, Tumor; Disease Models, Animal; Fluorodeoxyglucose F18; Humans; Inflammation; Iodine Radioisotopes; Metabolic Clearance Rate; Mice; Mice, SCID; Organ Specificity; Pancreatic Neoplasms; Phenylalanine; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution; Transplantation, Heterologous | 2005 |
Antithrombotic potential of new direct thrombin inhibitors built on the azaphenylalanine scaffold in two rat venous thrombosis models.
Topics: Administration, Oral; Animals; Anticoagulants; Arginine; Blood Coagulation Tests; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Fibrinolytic Agents; Injections, Subcutaneous; Male; Nadroparin; Phenylalanine; Pipecolic Acids; Rats; Rats, Wistar; Structure-Activity Relationship; Sulfonamides; Thrombin; Thrombophilia; Vena Cava, Inferior; Venous Thrombosis | 2005 |
In vivo characterization of 123/125I-2-iodo-L-phenylalanine in an R1M rhabdomyosarcoma athymic mouse model as a potential tumor tracer for SPECT.
Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Feasibility Studies; Iodine Radioisotopes; Male; Metabolic Clearance Rate; Mice; Mice, Nude; Organ Specificity; Phenylalanine; Radionuclide Imaging; Radiopharmaceuticals; Rhabdomyosarcoma; Tissue Distribution | 2005 |
Triple vasopeptidase inhibition of angiotensin-converting enzyme/neutral endopeptidase/endothelin-converting enzyme activities on the hemodynamic profile of chronically instrumented unrestrained conscious spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aspartic Acid Endopeptidases; Benzazepines; Benzofurans; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endothelin-Converting Enzymes; Heart Rate; Hypertension; Infusions, Intra-Arterial; Male; Metalloendopeptidases; Neprilysin; Organophosphonates; Phenylalanine; Rats; Rats, Inbred SHR; Time Factors | 2004 |
Crystallin {gamma}B-I4F mutant protein binds to {alpha}-crystallin and affects lens transparency.
Topics: alpha-Crystallins; Angiography; Animals; Chromatography, Gel; Circular Dichroism; Cloning, Molecular; Crystallins; Disease Models, Animal; DNA Primers; Electrophoresis, Gel, Two-Dimensional; Ethylnitrosourea; Fluorescein; gamma-Crystallins; Genetic Linkage; Homozygote; Immunohistochemistry; Isoleucine; Lens, Crystalline; Mice; Mice, Mutant Strains; Mutagenesis; Mutagens; Mutation; Mutation, Missense; Phenotype; Phenylalanine; Protein Binding; Recombinant Proteins; Retinal Vessels; Sequence Analysis, DNA; Ultraviolet Rays | 2005 |
Characterization of transgenic mice with the expression of phenylalanine hydroxylase and GTP cyclohydrolase I in the skin.
Topics: Animals; Base Sequence; Disease Models, Animal; DNA, Complementary; Gene Expression; Genetic Engineering; Genetic Therapy; GTP Cyclohydrolase; Humans; Keratin-14; Keratins; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Mice, Transgenic; Phenotype; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias; Promoter Regions, Genetic; Protein Precursors; Skin | 2005 |
Low therapeutic threshold for hepatocyte replacement in murine phenylketonuria.
Topics: Animals; Disease Models, Animal; Hepatocytes; Liver; Mice; Mice, Mutant Strains; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias | 2005 |
L-[1-13C] phenylalanine breath test results reflect the activity of phenylalanine hydroxylase in carbon tetrachloride acute injured rat liver.
Topics: Acute Disease; Animals; Breath Tests; Carbon Isotopes; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Liver; Male; Phenylalanine; Phenylalanine Hydroxylase; Rats; Rats, Sprague-Dawley | 2006 |
Reversal of gene expression profile in the phenylketonuria mouse model after adeno-associated virus vector-mediated gene therapy.
Topics: Animals; Dependovirus; Disease Models, Animal; Gene Expression Regulation; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; Mice; Mice, Mutant Strains; Oligonucleotide Array Sequence Analysis; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias; Transgenes; Up-Regulation | 2005 |
Effect of N-benzoyl-d-phenylalanine on lipid profile in liver of neonatal streptozotocin diabetic rats.
Topics: Administration, Oral; Animals; Animals, Newborn; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glutathione; Hypoglycemic Agents; Insulin; Lipid Peroxidation; Lipids; Liver; Male; Metformin; Phenylalanine; Rats; Rats, Wistar; Streptozocin; Thiobarbituric Acid Reactive Substances | 2005 |
Mitochondrial damage induced by fetal hyperphenylalaninemia in the rat brain and liver: its prevention by melatonin, Vitamin E, and Vitamin C.
Topics: Aldehydes; Animals; Animals, Newborn; Ascorbic Acid; Disease Models, Animal; Drug Interactions; Female; Male; Malondialdehyde; Melatonin; Mitochondrial Diseases; Phenethylamines; Phenylalanine; Phenylketonurias; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Time Factors; Vitamin A | 2006 |
In vivo evaluation and dosimetry of 123I-2-iodo-D-phenylalanine, a new potential tumor-specific tracer for SPECT, in an R1M rhabdomyosarcoma athymic mouse model.
Topics: Animals; Calibration; Chromatography, High Pressure Liquid; Cluster Analysis; Disease Models, Animal; Evaluation Studies as Topic; Humans; Image Processing, Computer-Assisted; Inflammation; Iodine Radioisotopes; Kinetics; Male; Mice; Mice, Nude; Phenylalanine; Radiation Dosage; Radiometry; Radionuclide Imaging; Radiopharmaceuticals; Rhabdomyosarcoma; Time Factors; Tomography, Emission-Computed, Single-Photon | 2005 |
A small molecule, orally active, alpha4beta1/alpha4beta7 dual antagonist reduces leukocyte infiltration and airway hyper-responsiveness in an experimental model of allergic asthma in Brown Norway rats.
Topics: Allergens; Animals; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Gene Expression Regulation; Integrin alpha4beta1; Integrins; Interleukin-4; Interleukin-5; Leukocyte Rolling; Leukocytes; Lung; Male; Mesenteric Veins; Ovalbumin; Phenylalanine; Pneumonia; Rats; Rats, Inbred BN; RNA, Messenger; Serotonin | 2006 |
Influence of sedation and data acquisition method on tracer uptake in animal models: [123I]-2-iodo-L-phenylalanine in pentobarbital-sedated tumor-bearing athymic mice.
Topics: Animals; Artifacts; Cell Line, Tumor; Disease Models, Animal; Hypnotics and Sedatives; Image Interpretation, Computer-Assisted; Iodine Radioisotopes; Male; Metabolic Clearance Rate; Mice; Mice, Nude; Organ Specificity; Pentobarbital; Phenylalanine; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Rhabdomyosarcoma; Sensitivity and Specificity; Tissue Distribution | 2006 |
A murine model for human sepiapterin-reductase deficiency.
Topics: Alcohol Oxidoreductases; Animals; Base Sequence; Biopterins; Catecholamines; Disease Models, Animal; DNA Primers; Growth; Humans; Immunohistochemistry; Locomotion; Metabolism, Inborn Errors; Mice; Mice, Knockout; Phenotype; Phenylalanine; Serotonin | 2006 |
Comparison of the pharmacology of hydroxamate- and carboxylate-based matrix metalloproteinase inhibitors (MMPIs) for the treatment of osteoarthritis.
Topics: Amino Acids; Animals; Carboxylic Acids; Cartilage; Disease Models, Animal; Humans; Hydroxamic Acids; Iodoacetates; Knee Joint; Male; Matrix Metalloproteinase Inhibitors; Molecular Structure; Osteoarthritis; Phenylalanine; Plasma; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Sulfonamides; Sulfones | 2006 |
EGF receptor antagonism improves survival in a murine model of pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Animals; Cell Division; Cell Line, Tumor; Disease Models, Animal; ErbB Receptors; Erlotinib Hydrochloride; Gene Expression; Humans; Mice; Mice, Nude; Pancreatic Neoplasms; Phenylalanine; Protease Inhibitors; Protein Kinase Inhibitors; Quinazolines; Survival Rate; Thiophenes | 2006 |
Homogeneous boron targeting of heterogeneous tumors for boron neutron capture therapy (BNCT): chemical analyses in the hamster cheek pouch oral cancer model.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Borohydrides; Boron Compounds; Boron Neutron Capture Therapy; Cheek; Cricetinae; Disease Models, Animal; Mesocricetus; Mouth Mucosa; Mouth Neoplasms; Phenylalanine; Precancerous Conditions | 2006 |
JTE-607, a multiple cytokine production inhibitor, ameliorates disease in a SCID mouse xenograft acute myeloid leukemia model.
Topics: Animals; Autocrine Communication; Cell Proliferation; Cytokines; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Humans; Interleukin-8; Leukemia, Myeloid, Acute; Leukocyte Common Antigens; Mice; Mice, SCID; Neoplasm Transplantation; Neoplasms, Experimental; Paracrine Communication; Phenylalanine; Piperazines; Transplantation, Heterologous | 2006 |
Glibenclamide attenuates the antiarrhythmic effect of endotoxin with a mechanism not involving K(ATP) channels.
Topics: Action Potentials; Adenosine Triphosphate; Animals; Arrhythmias, Cardiac; Blood Pressure; Carbamates; Cyclohexanes; Disease Models, Animal; Drug Interactions; Endotoxemia; Glyburide; Heart Atria; Heart Conduction System; Lipopolysaccharides; Male; Myocardial Ischemia; Nateglinide; Phenylalanine; Piperidines; Potassium Channel Blockers; Potassium Channels; Rats; Rats, Sprague-Dawley; Tachycardia, Ventricular; Tetraethylammonium; Time Factors; Ventricular Fibrillation; Ventricular Premature Complexes | 2007 |
PKU is a reversible neurodegenerative process within the nigrostriatum that begins as early as 4 weeks of age in Pah(enu2) mice.
Topics: Amino Acid Oxidoreductases; Animals; Biogenic Monoamines; Corpus Striatum; Dependovirus; Disease Models, Animal; Female; Genetic Therapy; Genetic Vectors; Male; Mice; Mice, Neurologic Mutants; Nerve Degeneration; Neural Pathways; Neurodegenerative Diseases; Neuroglia; Neurons; Oxidative Stress; Phenylalanine; Phenylketonurias; Substantia Nigra; Treatment Outcome | 2007 |
Effect of synthetic matrix metalloproteinase inhibitors on lipopolysaccharide-induced blood-brain barrier opening in rodents: Differences in response based on strains and solvents.
Topics: Animals; Benzyl Compounds; Blood-Brain Barrier; Dexamethasone; Dimethyl Sulfoxide; Disease Models, Animal; Drug Combinations; Drug Evaluation, Preclinical; Encephalitis; Endothelial Cells; Enzyme Inhibitors; Genetic Variation; Heterocyclic Compounds, 1-Ring; Inflammation Mediators; Lipopolysaccharides; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Pentoxifylline; Phenylalanine; Rats; Rats, Inbred WKY; Solvents; Species Specificity; Succinates; Sulfones; Thiophenes | 2007 |
Preproenkephalin knockout mice show no depression-related phenotype.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Depression; Disease Models, Animal; Disulfides; Dose-Response Relationship, Drug; Enkephalins; Enzyme Inhibitors; Hindlimb Suspension; Immobility Response, Tonic; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Knockout; Motor Activity; Nialamide; Phenotype; Phenylalanine; Protein Precursors; Swimming; Vocalization, Animal | 2007 |
Epilepsy in phenylketonuria: a complex dependence on serum phenylalanine levels.
Topics: Acoustic Stimulation; Age Factors; Animals; Circadian Rhythm; Disease Models, Animal; Epilepsy; Epilepsy, Reflex; Female; Food, Formulated; Genetic Predisposition to Disease; Mice; Mice, Mutant Strains; Phenylalanine; Phenylketonurias | 2007 |
Effect of Boron Neutron Capture Therapy (BNCT) on normal liver regeneration: towards a novel therapy for liver metastases.
Topics: Animals; Body Weight; Boron Compounds; Boron Neutron Capture Therapy; Disease Models, Animal; DNA; Dose-Response Relationship, Radiation; Hepatocytes; Humans; Kidney; Liver; Liver Neoplasms; Liver Regeneration; Male; Organ Size; Phenylalanine; Radiotherapy Dosage; Rats; Rats, Wistar | 2007 |
Involvement of specific matrix metalloproteinases during tumor necrosis factor/IFNgamma-based cancer therapy in mice.
Topics: Animals; Antiviral Agents; Disease Models, Animal; Interferon-gamma; Matrix Metalloproteinase 12; Matrix Metalloproteinase 7; Matrix Metalloproteinase 8; Matrix Metalloproteinase 9; Matrix Metalloproteinases; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Knockout; Phenylalanine; Reverse Transcriptase Polymerase Chain Reaction; Thiophenes; Tissue Inhibitor of Metalloproteinases; Tumor Necrosis Factor-alpha | 2007 |
Interaction between murine spf-ash mutation and genetic background yields different metabolic phenotypes.
Topics: Alanine; Ammonia; Animals; Arginine; Citrulline; Disease Models, Animal; Female; Glycine; Injections, Intravenous; Intestinal Mucosa; Liver; Male; Mice; Mice, Inbred ICR; Mice, Inbred Strains; Mice, Mutant Strains; Models, Biological; Mutation; Nitric Oxide; Ornithine; Ornithine Carbamoyltransferase; Ornithine Carbamoyltransferase Deficiency Disease; Phenotype; Phenylalanine; Urea | 2007 |
Resuscitation of hypoxic newborn piglets with oxygen induces a dose-dependent increase in markers of oxidation.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Animals, Newborn; Biomarkers; Chromatography, High Pressure Liquid; Deoxyguanosine; Disease Models, Animal; DNA Damage; Dose-Response Relationship, Drug; Female; Hypoxia; Male; Oxidative Stress; Oxygen; Oxygen Inhalation Therapy; Phenylalanine; Reactive Oxygen Species; Respiration, Artificial; Swine; Tandem Mass Spectrometry; Time Factors; Tyrosine | 2007 |
Chromium (D-phenylalanine)3 improves obesity-induced cardiac contractile defect in ob/ob mice.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Glucose; Homeodomain Proteins; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Myocardial Contraction; Myocytes, Cardiac; Obesity; Organometallic Compounds; Oxidative Stress; Phenylalanine; Picolinic Acids; Proto-Oncogene Proteins c-akt; Receptor, Insulin; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Sodium-Calcium Exchanger; Thinness | 2007 |
Nateglinide prevents fatty liver through up-regulation of lipid oxidation pathway in Goto-Kakizaki rats on a high-fat diet.
Topics: Animals; Blood Glucose; Cyclohexanes; Dietary Fats; Disease Models, Animal; Fatty Acids, Nonesterified; Fatty Liver; Hypoglycemic Agents; Insulin; Male; Nateglinide; Phenylalanine; Rats; Rats, Inbred Strains; Rats, Wistar; Triglycerides | 2008 |
Dietary glycomacropeptide supports growth and reduces the concentrations of phenylalanine in plasma and brain in a murine model of phenylketonuria.
Topics: Animals; Body Weight; Brain; Diet; Dietary Supplements; Disease Models, Animal; Feeding Behavior; Female; Glycopeptides; Male; Mice; Phenylalanine; Phenylketonurias | 2008 |
Efficacy of TG101348, a selective JAK2 inhibitor, in treatment of a murine model of JAK2V617F-induced polycythemia vera.
Topics: Amino Acid Substitution; Animals; Bone Marrow Transplantation; Cell Line, Tumor; Colony-Forming Units Assay; Disease Models, Animal; Endpoint Determination; Flow Cytometry; Hematopoietic System; Humans; Janus Kinase 2; Mice; Mice, Inbred C57BL; Phenylalanine; Polycythemia Vera; Protein Kinase Inhibitors; Pyrrolidines; Signal Transduction; Sulfonamides; Survival Rate; Treatment Outcome; Valine | 2008 |
Effect of hyperphenylalaninemia on Na+ + K+-ATPase in rat brain.
Topics: Adenosine Triphosphatases; Animals; Brain; Ca(2+) Mg(2+)-ATPase; Disease Models, Animal; Enzyme Activation; Fenclonine; Kinetics; Mitochondria; Ouabain; Phenylalanine; Rats; Rats, Inbred Strains; Sodium-Potassium-Exchanging ATPase; Synaptosomes | 1981 |
Analysis of learning in retarded monkeys.
Topics: Animals; Attention; Concept Formation; Discrimination, Psychological; Disease Models, Animal; Female; Fenclonine; Humans; Learning; Macaca mulatta; Phenylalanine; Phenylketonurias; Pregnancy; Reinforcement, Psychology; Retention, Psychology | 1984 |
Effect of hyperphenylalaninemia induced during suckling on brain DNA metabolism in rat pups.
Topics: Amino Acid Metabolism, Inborn Errors; Animals; Brain; Cell Division; Disease Models, Animal; DNA; DNA Replication; Fenclonine; Kinetics; Phenylalanine; Rats; Rats, Inbred Strains | 1984 |
Effect of hyperphenylalaninemia on polyphosphoinositides content of rat brain.
Topics: Animals; Brain; Disease Models, Animal; Fenclonine; Humans; Kinetics; Phenylalanine; Phenylketonurias; Phosphatidylinositols; Phospholipids; Rats; Rats, Inbred Strains | 1982 |
Characterization of experimental phenylketonuria. Augmentation of hyperphenylalaninemia with alpha-methylphenylalanine and p-chlorophenylalanine.
Topics: Age Factors; Amino Acids; Animals; Behavior, Animal; Body Weight; Brain Chemistry; Disease Models, Animal; Fenclonine; Humans; Learning; Myelin Proteins; Phenylalanine; Phenylketonurias; Phenylpyruvic Acids; Rats | 1980 |
Phenylketonuria: clinical and experimental considerations revealed by the use of animal models.
Topics: Animals; Brain; Cerebellum; Disease Models, Animal; Fenclonine; Humans; Male; Neurons; Phenylalanine; Phenylketonurias; Rats | 1980 |
Induction of an experimental phenylketonuria-like condition in infant rats during the first 2 weeks after birth.
Topics: Animals; Animals, Newborn; Diet; Disease Models, Animal; Female; Fenclonine; Humans; Male; Methotrexate; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias; Rats; Tyrosine | 1981 |
Disturbances of amino acid transport in rats with experimental hyperphenylalaninaemia.
Topics: Amino Acids; Animals; Cerebral Cortex; Disease Models, Animal; Fenclonine; Glycine; Humans; Leucine; Liver; Phenylalanine; Phenylketonurias; Rats; Tryptophan | 1981 |
Antiinflammatory activity of N-(2-benzoylphenyl)alanine derivatives.
Topics: Animals; Anti-Inflammatory Agents; Arthritis; Arthritis, Experimental; Chemical Phenomena; Chemistry; Disease Models, Animal; Indicators and Reagents; Indomethacin; Phenylalanine; Pleurisy; Rats; Structure-Activity Relationship | 1984 |
PKU, learning, and models of mental retardation.
Topics: Animals; Body Weight; Disease Models, Animal; Humans; Intellectual Disability; Learning; Phenylalanine; Phenylketonurias; Psychological Tests; Rats | 1984 |
Hyperalphalipoproteinaemic activity of BRL 26314--II. Inhibition of atherosclerosis in rabbits.
Topics: Animals; Arteriosclerosis; Cholesterol; Disease Models, Animal; Hyperlipoproteinemias; Lipoproteins, HDL; Male; Phenylalanine; Rabbits | 1984 |
In vivo safety of hollow fiber enzyme-reactors with immobilized phenylalanine ammonia-lyase in a large animal model for phenylketonuria.
Topics: Ammonia-Lyases; Animals; Blood Cells; Blood Urea Nitrogen; Disease Models, Animal; Dogs; Enzymes, Immobilized; Female; Humans; Macaca; Male; Phenylalanine; Phenylalanine Ammonia-Lyase; Phenylketonurias; Time Factors; Tyrosine | 1983 |
Morphological and functional changes in the gut after massive small bowel resection and colon interposition in rhesus monkeys.
Topics: Adaptation, Physiological; Alanine; Animals; Colon; Disease Models, Animal; Glucose; Hyperplasia; Hypertrophy; Intestine, Small; Macaca mulatta; Malabsorption Syndromes; Nucleic Acids; Phenylalanine; Short Bowel Syndrome | 1984 |
Use of alpha-methylphenylalanine for studies of brain development in experimental phenylketonuria.
Topics: Animals; Brain; Cell Division; Cell Survival; Cerebellum; Disease Models, Animal; Humans; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias; Rats | 1981 |
Turnover of the fast components of myelin and myelin proteins in experimental hyperphenylalaninaemia. Relevance to termination of dietary treatment in human phenylketonuria.
Topics: Amino Acid Metabolism, Inborn Errors; Animals; Disease Models, Animal; Half-Life; Humans; Lysine; Myelin Proteins; Myelin Sheath; Phenylalanine; Phenylketonurias; Rats; Rats, Inbred Strains | 1982 |
Brain development in experimental hyperphenylalaninaemia: myelination.
Topics: Animals; Brain; Disease Models, Animal; Humans; Microscopy, Electron; Myelin Sheath; Nerve Fibers, Myelinated; Phenylalanine; Phenylketonurias; Rats; Rats, Inbred Strains; Spinal Cord | 1982 |
Retarded development of neurons and oligodendroglia in rat forebrain produced by hyperphenylalaninemia results in permanent deficits in myelin despite long recovery periods.
Topics: Animals; Animals, Newborn; Axons; Corpus Callosum; Disease Models, Animal; Female; Male; Molecular Weight; Myelin Basic Protein; Myelin Sheath; Neurofilament Proteins; Neurons; Oligodendroglia; Phenylalanine; Phenylketonurias; Prosencephalon; Rats; Rats, Sprague-Dawley | 1993 |
An animal model of early-treated PKU.
Topics: Animals; Animals, Newborn; Behavior, Animal; Disease Models, Animal; Drug Therapy, Combination; Fetus; Homovanillic Acid; Hydroxyindoleacetic Acid; Injections; Neurotransmitter Agents; Phenylalanine; Phenylketonurias; Rats; Rats, Inbred Strains; Time Factors | 1994 |
Neocortical dialysate monoamines of rats after acute, subacute, and chronic liver shunt.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acute Disease; Amino Acids; Ammonia; Animals; Biogenic Monoamines; Body Weight; Cerebral Cortex; Chronic Disease; Dialysis; Disease Models, Animal; Dopamine; Extracellular Space; Hepatic Encephalopathy; Hydroxyindoleacetic Acid; Male; Norepinephrine; Phenylalanine; Rats; Rats, Wistar; Serotonin; Tryptophan; Tyrosine | 1995 |
A new theory of enterorecirculation of amino acids and its use for depleting unwanted amino acids using oral enzyme-artificial cells, as in removing phenylalanine in phenylketonuria.
Topics: Amino Acids; Animals; Body Weight; Diet, Protein-Restricted; Disease Models, Animal; Dosage Forms; Drug Compounding; Intestinal Mucosa; Intestinal Secretions; Intestines; Male; Models, Biological; Phenylalanine; Phenylalanine Ammonia-Lyase; Phenylketonurias; Rats; Rats, Sprague-Dawley; Time Factors | 1995 |
High protein diet has beneficial effects in murine muscular dystrophy.
Topics: Animals; Dietary Proteins; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Methylhistidines; Mice; Mice, Mutant Strains; Muscle Proteins; Muscle, Skeletal; Muscular Dystrophy, Animal; Phenylalanine; Time Factors | 1995 |
Response of the central nervous system to boron neutron capture irradiation: evaluation using rat spinal cord model.
Topics: Absorption; Animals; Blood-Brain Barrier; Borohydrides; Boron; Boron Compounds; Boron Neutron Capture Therapy; Disease Models, Animal; Dose-Response Relationship, Radiation; Isotopes; Linear Energy Transfer; Male; Phenylalanine; Radiation-Sensitizing Agents; Radiotherapy Dosage; Rats; Rats, Inbred F344; Relative Biological Effectiveness; Spinal Cord; Spinal Cord Diseases; Sulfhydryl Compounds | 1994 |
Effect of phenylalanine and its metabolites on ATP diphosphohydrolase activity in synaptosomes from rat cerebral cortex.
Topics: Animals; Apyrase; Cerebral Cortex; Disease Models, Animal; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias; Rats; Rats, Wistar; Synaptosomes | 1994 |
Effect of long-term cyclic mechanical load on protein synthesis and morphological changes in cultured myocardial cells from neonatal rat.
Topics: Animals; Animals, Newborn; Carbon Radioisotopes; Cardiomegaly; Cell Size; Cells, Cultured; Disease Models, Animal; Heart; Microscopy; Microscopy, Electron; Myocardium; Phenylalanine; Physical Stimulation; Protein Biosynthesis; Rats; Rats, Sprague-Dawley; Thymidine; Time Factors; Tritium | 1994 |
Phe1-substituted beta-casomorphin-5 analogues with analgesic activity.
Topics: Amino Acid Sequence; Analgesics; Animals; Disease Models, Animal; Drug Tolerance; Endorphins; Male; Molecular Sequence Data; Morphine; Pain; Peptide Fragments; Phenylalanine; Rats; Rats, Wistar; Vocalization, Animal | 1994 |
Matrix metalloproteinase inhibitor BB-94 (batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice.
Topics: Adenocarcinoma, Mucinous; Animals; Colonic Neoplasms; Disease Models, Animal; Drug Screening Assays, Antitumor; Female; Humans; Male; Metalloendopeptidases; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Transplantation; Phenylalanine; Thiophenes; Transplantation, Heterologous | 1994 |
The effect of hyperphenylalaninaemia on the muscarinic acetylcholine receptor in the HPH-5 mouse brain.
Topics: Animals; Brain; Brain Chemistry; Disease Models, Animal; Metabolism, Inborn Errors; Mice; Mice, Mutant Strains; Phenylalanine; Phenylalanine Hydroxylase; Protein Binding; Quinuclidinyl Benzilate; Receptors, Dopamine D1; Receptors, Muscarinic | 1993 |
Experimental research on a new treatment for maternal phenylketonuria(PKU).
Topics: Animals; Biopterins; Brain; Disease Models, Animal; Female; Fetus; Guinea Pigs; Infusions, Intravenous; Liver; Phenylalanine; Phenylketonurias; Pregnancy; Pregnancy Complications; Tyrosine | 1993 |
Mouse models of human phenylketonuria.
Topics: Animals; Blotting, Western; Cross Reactions; Diet; Disease Models, Animal; Genotype; Humans; Mice; Mutagenesis; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias | 1993 |
Cellular accumulation of 18F-labelled boronophenylalanine depending on DNA synthesis and melanin incorporation: a double-tracer microautoradiographic study of B16 melanomas in vivo.
Topics: Animals; Autoradiography; Boron Compounds; Boron Neutron Capture Therapy; Cell Division; Disease Models, Animal; DNA, Neoplasm; Fluorine Radioisotopes; Male; Melanins; Melanoma, Experimental; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Neoplasm Transplantation; Phenylalanine; Pigmentation; Radionuclide Imaging | 1993 |
Genetic mapping of hph2, a mutation affecting amino acid transport in the mouse.
Topics: Animals; Biological Transport; Chromosome Mapping; Crosses, Genetic; Disease Models, Animal; Hartnup Disease; Humans; Mice; Mice, Inbred C57BL; Mutation; Phenylalanine | 1997 |
A candidate mouse model for Hartnup disorder deficient in neutral amino acid transport.
Topics: Animals; Biological Transport; Blood Glucose; Disease Models, Animal; Glycosuria; Hartnup Disease; Humans; Kidney; Mice; Phenylalanine | 1997 |
Effect of experimental hyperphenylalaninemia on the postnatal rat brain.
Topics: Animals; Cerebellum; Disease Models, Animal; Extracellular Matrix; Glial Fibrillary Acidic Protein; Hyaluronic Acid; Nerve Tissue Proteins; Neural Cell Adhesion Molecules; Phenylalanine; Phenylketonurias; Rats; Rats, Wistar; Telencephalon | 1997 |
Cardiovascular defects among the progeny of mouse phenylketonuria females.
Topics: Animals; Blood Vessels; Diet; Disease Models, Animal; Female; Genotype; Heart Defects, Congenital; Humans; Maternal-Fetal Exchange; Mice; Phenylalanine; Phenylketonurias; Pregnancy; Pregnancy Complications | 1997 |
The matrix metalloproteinase inhibitor BB-94 limits expansion of experimental abdominal aortic aneurysms.
Topics: Animals; Antibodies, Monoclonal; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Disease Models, Animal; Male; Metalloendopeptidases; Phenylalanine; Protease Inhibitors; Rats; Rats, Wistar; Thiophenes | 1999 |
A different approach to treatment of phenylketonuria: phenylalanine degradation with recombinant phenylalanine ammonia lyase.
Topics: Animals; Basidiomycota; Cloning, Molecular; Disease Models, Animal; Escherichia coli; Ethylnitrosourea; Humans; Injections, Intraperitoneal; Mice; Phenylalanine; Phenylalanine Ammonia-Lyase; Phenylketonurias; Recombinant Proteins | 1999 |
Retinal neovascularization is suppressed with a matrix metalloproteinase inhibitor.
Topics: Animals; Animals, Newborn; Collagenases; Disease Models, Animal; Gelatinases; Injections, Intraperitoneal; Ischemia; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Metalloendopeptidases; Mice; Mice, Inbred C57BL; Phenylalanine; Protease Inhibitors; Retina; Retinal Neovascularization; Retinal Vessels; Thiophenes; Urokinase-Type Plasminogen Activator | 1999 |
A heteroallelic mutant mouse model: A new orthologue for human hyperphenylalaninemia.
Topics: Alleles; Animals; Behavior, Animal; Blotting, Western; Disease Models, Animal; Female; Genotype; Humans; Liver; Male; Mental Disorders; Mice; Mutation; Phenotype; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias | 2000 |
Fractalkine cleavage from neuronal membranes represents an acute event in the inflammatory response to excitotoxic brain damage.
Topics: Animals; Animals, Newborn; Brain; Cell Membrane; Cells, Cultured; Chemokine CX3CL1; Chemokines, CX3C; Chemotaxis; Culture Media, Conditioned; Disease Models, Animal; Encephalitis; Endothelium, Vascular; Glutamic Acid; Infarction, Middle Cerebral Artery; Interleukin-1; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Membrane Proteins; Microglia; Monocytes; Neurons; Phenylalanine; Protease Inhibitors; Rats; RNA, Messenger; Thiophenes; Transfection; Tumor Necrosis Factor-alpha | 2000 |
Is there a relationship between 3-hydroxy-3-methylglutaryl coenzyme a reductase activity and forebrain pathology in the PKU mouse?
Topics: Alkyl and Aryl Transferases; Animals; Brain Chemistry; Cell Count; Cell Line; Cholesterol; Demyelinating Diseases; Disease Models, Animal; Farnesyltranstransferase; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver; Mice; Mice, Neurologic Mutants; Mice, Transgenic; Microsomes; Myelin Basic Protein; Oligodendroglia; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias; Prosencephalon; Rhombencephalon | 2000 |
Exploiting changes in the tumour microenvironment with sequential cytokine and matrix metalloprotease inhibitor treatment in a murine breast cancer model.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Disease Models, Animal; Drug Administration Schedule; Drug Synergism; Female; Interleukin-12; Mammary Neoplasms, Experimental; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Phenylalanine; Protease Inhibitors; Thiophenes | 2000 |
A quantitative evaluation of the permeability of the blood brain barrier of portacaval shunted rats.
Topics: Acetates; Animals; Blood-Brain Barrier; Brain; Carbon Radioisotopes; Cerebrovascular Circulation; Disease Models, Animal; Glutamic Acid; Hepatic Encephalopathy; Male; Mannitol; Permeability; Phenylalanine; Portacaval Shunt, Surgical; Rats; Rats, Sprague-Dawley; Tritium | 2000 |
Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke.
Topics: Animals; Cerebral Hemorrhage; Disease Models, Animal; Fibrinolytic Agents; Humans; Intracranial Embolism; Metalloendopeptidases; Phenylalanine; Protease Inhibitors; Rabbits; Stroke; Thiophenes; Thromboembolism; Tissue Plasminogen Activator | 2000 |
Characterization of the mouse phenylalanine hydroxylase mutation Pah(enu3).
Topics: Alleles; Animals; Base Sequence; Disease Models, Animal; DNA Mutational Analysis; DNA, Complementary; Exons; Frameshift Mutation; Gene Deletion; Humans; Introns; Male; Mice; Models, Genetic; Molecular Sequence Data; Mutagenesis; Mutation; Mutation, Missense; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias; RNA Splice Sites; RNA, Messenger; Sequence Homology, Nucleic Acid | 2001 |
A possible role for metalloproteinases in renal cyst development.
Topics: Animals; Disease Models, Animal; Kidney; Matrix Metalloproteinases, Membrane-Associated; Metalloendopeptidases; Phenylalanine; Polycystic Kidney, Autosomal Dominant; Protease Inhibitors; Rats; Rats, Inbred Strains; RNA, Messenger; Thiophenes; Tissue Inhibitor of Metalloproteinase-2; Transforming Growth Factor beta; Transforming Growth Factor beta2 | 2001 |
Validation of an orthotopic model of human lung cancer with regional and systemic metastases.
Topics: Analysis of Variance; Animals; Antineoplastic Agents; Carcinoma, Large Cell; Cisplatin; Disease Models, Animal; Doxorubicin; Humans; Lung Neoplasms; Male; Mitomycin; Neoplasm Invasiveness; Neoplasm Transplantation; Phenylalanine; Rats; Rats, Nude; Survival Rate; Thiophenes; Treatment Outcome; Xenograft Model Antitumor Assays | 2001 |
Higher skeletal muscle protein synthesis and lower breakdown after chemotherapy in cachectic mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cachexia; Colonic Neoplasms; Disease Models, Animal; Male; Mice; Mice, Inbred BALB C; Muscle Proteins; Muscle, Skeletal; Nitrosourea Compounds; Organ Size; Phenylalanine | 2001 |
Beneficial effects of Batimastat (BB-94), a matrix metalloproteinase inhibitor, in rat experimental colitis.
Topics: Animals; Chronic Disease; Colitis, Ulcerative; Disease Models, Animal; Hematoxylin; Intestinal Mucosa; Male; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Peroxidase; Phenylalanine; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Thiophenes; Trinitrobenzenesulfonic Acid | 2001 |
Regulation of matrix metalloproteinase activity in ischemic tissue by interleukin-10: role in ischemia-induced angiogenesis.
Topics: Angiography; Animals; Blood Flow Velocity; Capillaries; Disease Models, Animal; Endothelial Growth Factors; Enzyme Activation; Femoral Artery; Fibroblast Growth Factor 2; Hindlimb; Interleukin-10; Ischemia; Laser-Doppler Flowmetry; Lymphokines; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Mice, Knockout; Neovascularization, Pathologic; Phenylalanine; Platelet Endothelial Cell Adhesion Molecule-1; Protease Inhibitors; Thiophenes; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2001 |
[An experimental study of matrix metalloproteinase inhibitor BB-94 inhibits the invasion and metastasis of the human salivary adenoid cystic carcinoma in vitro and in vivo].
Topics: Animals; Carcinoma, Adenoid Cystic; Disease Models, Animal; Female; Lung Neoplasms; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Phenylalanine; Protease Inhibitors; Salivary Gland Diseases; Thiophenes | 2001 |
Effect of maternal blood phenylalanine level on mouse maternal phenylketonuria offspring.
Topics: Abortion, Spontaneous; Animals; Disease Models, Animal; Embryonic and Fetal Development; Female; Fetal Diseases; Humans; Male; Mice; Phenylalanine; Phenylketonuria, Maternal; Pregnancy; Tyrosine | 2001 |
Boron neutron capture therapy for the treatment of oral cancer in the hamster cheek pouch model.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Boron Compounds; Boron Neutron Capture Therapy; Carcinogens; Cheek; Cricetinae; Disease Models, Animal; Mesocricetus; Mouth Neoplasms; Phenylalanine; Precancerous Conditions; Radiation-Sensitizing Agents | 2001 |
The hamster cheek pouch as a model of oral cancer for boron neutron capture therapy studies: selective delivery of boron by boronophenylalanine.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Boron; Boron Compounds; Boron Neutron Capture Therapy; Carcinogens; Cheek; Cricetinae; Disease Models, Animal; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Injections, Intravenous; Injections, Subcutaneous; Mesocricetus; Mouth Neoplasms; Phenylalanine; Radiation-Sensitizing Agents; Tissue Distribution | 2001 |
Prostate cancer in bone: importance of context for inhibition of matrix metalloproteinases.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Disease Models, Animal; Humans; Male; Matrix Metalloproteinase Inhibitors; Neoplasm Metastasis; Phenylalanine; Prostatic Neoplasms; Thiophenes | 2002 |
Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bone Neoplasms; Bone Remodeling; Bone Transplantation; Calcium; Disease Models, Animal; Fetal Tissue Transplantation; Humans; Immunohistochemistry; In Situ Hybridization; Male; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Mice; Mice, SCID; Neoplasm Metastasis; Oligonucleotide Probes; Osteoclasts; Phenylalanine; Prostatic Neoplasms; RNA, Messenger; Thiophenes; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2002 |
Long-term therapy with NTBC and tyrosine-restricted diet in a murine model of hereditary tyrosinemia type I.
Topics: Animals; Cyclohexanones; Diet; Disease Models, Animal; Enzyme Inhibitors; Hydrolases; Mice; Mice, Knockout; Nitrobenzoates; Phenylalanine; Tyrosine; Tyrosinemias | 2002 |
Quantitation of cell migration in a rat carotid artery balloon injury model. Indications for a perivascular origin of the neointimal cells.
Topics: Animals; Carotid Arteries; Carotid Artery Injuries; Catheterization; Cell Count; Cell Division; Cell Movement; Cyclophosphamide; Disease Models, Animal; Male; Metalloendopeptidases; Muscle, Smooth, Vascular; Phenylalanine; Rats; Rats, Sprague-Dawley; Rats, Wistar; Thiophenes; Tunica Intima | 2001 |
Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats.
Topics: Animals; Blood Flow Velocity; Brain; Brain Ischemia; Cerebral Hemorrhage; Cerebrovascular Circulation; Disease Models, Animal; Enzyme Inhibitors; Intracranial Embolism; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Phenylalanine; Rats; Rats, Inbred SHR; Sodium, Dietary; Survival Rate; Thiophenes; Thrombolytic Therapy; Tissue Plasminogen Activator | 2002 |
Oxidative stress in a phenylketonuria animal model.
Topics: Animals; Brain; Catalase; Chromatography, High Pressure Liquid; Disease Models, Animal; Erythrocytes; Glucosephosphate Dehydrogenase; Glutathione; Hydrogen Peroxide; Lipid Peroxidation; Malondialdehyde; Mice; Mice, Knockout; NADP; Oxidation-Reduction; Oxidative Stress; Oxygen; Phenylalanine; Phenylketonurias | 2002 |
L-arginine supplementation in pigs decreases liver protein turnover and increases hindquarter protein turnover both during and after endotoxemia.
Topics: Acute-Phase Proteins; Animals; Arginine; Blood Gas Analysis; Dietary Supplements; Disease Models, Animal; Endotoxemia; Enteral Nutrition; Female; Hindlimb; Isomerism; Kidney; Liver; Muscle, Skeletal; Phenylalanine; Proteins; Random Allocation; Sepsis; Swine; Viscera | 2002 |
Metalloproteinase inhibitor attenuates neointima formation and constrictive remodeling after angioplasty in rats: augmentative effect of alpha(v)beta(3) receptor blockade.
Topics: Angioplasty, Balloon; Animals; Arteries; Cell Movement; Constriction, Pathologic; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Hydroxamic Acids; Hyperplasia; Male; Matrix Metalloproteinase Inhibitors; Muscle, Smooth, Vascular; Oligopeptides; Phenylalanine; Rats; Receptors, Vitronectin; Thiophenes; Tunica Intima | 2002 |
Monkey retardate learning analysis.
Topics: Age Factors; Animals; Choice Behavior; Conditioning, Operant; Diet; Discrimination Learning; Disease Models, Animal; Frontal Lobe; Haplorhini; Humans; Inhibition, Psychological; Intellectual Disability; Macaca mulatta; Phenylalanine; Phenylketonurias | 1978 |
Ultrastructural changes in rat optic nerve associated with hyperphenylalaninemia induced by para-chlorophenylalanine and phenylalanine.
Topics: Animals; Astrocytes; Axons; Cytoplasm; Disease Models, Animal; Endoplasmic Reticulum; Fenclonine; Golgi Apparatus; Humans; Microscopy, Electron; Myelin Sheath; Nerve Degeneration; Oligodendroglia; Optic Nerve; Phenylalanine; Phenylketonurias; Rats; Rats, Inbred F344; Sodium Chloride | 1975 |
Urinary metabolites of phenylalanine in the preweanling rat treated with p-chlorophenylalanine and phenylalanine.
Topics: Animals; Chromatography; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Fenclonine; Hippurates; Humans; Lactation; Male; Molecular Conformation; Phenylacetates; Phenylalanine; Phenylketonurias; Pregnancy; Rats | 1975 |
Brain uptake and protein incorporation of amino acids studied in rats subjected to prolonged hyperphenylalaninaemia.
Topics: Amino Acids; Animals; Brain; Disease Models, Animal; Female; Fenclonine; Glycine; Humans; Leucine; Lysine; Male; Nerve Tissue Proteins; Phenylalanine; Phenylketonurias; Rats | 1975 |
Model phenylketonuria (PKU) in the albino rat: behaviroal, biochemical, and neuroanatomical effects.
Topics: Animals; Axons; Body Weight; Disease Models, Animal; Emotions; Fenclonine; Humans; Learning; Liver; Motor Activity; Myelin Sheath; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias; Rats; Social Behavior; Tryptophan | 1975 |
Degradation of cartilage proteoglycan by human leukocyte granule neutral proteases--a model of joint injury. I. Penetration of enzyme into rabbit articular cartilage and release of 35SO4-labeled material from the tissue.
Topics: alpha 1-Antitrypsin; Animals; Cartilage, Articular; Chymotrypsin; Cytoplasmic Granules; Disease Models, Animal; Enzyme Inhibitors; Glycosaminoglycans; Humans; Immune Sera; Joint Diseases; Kinetics; Leukocytes; Oligopeptides; Pancreatic Elastase; Peptide Hydrolases; Phenylalanine; Proteoglycans; Rabbits; Sulfur Radioisotopes | 1976 |
The regulation of phenylalanine hydroxylase in rat tissues in vivo. The maintenance of high plasma phenylalanine concentrations in suckling rats: a model for phenylketonuria.
Topics: Animals; Brain; Disease Models, Animal; Fenclonine; Humans; Kidney; Liver; Male; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias; Rats; Tyrosine | 1976 |
Study of blood aminoacids in experimental hyperphenylalaninemia.
Topics: Amino Acids; Animals; Disease Models, Animal; Fenclonine; Humans; Male; Phenylalanine; Phenylketonurias; Rats; Sulfamethoxazole; Trimethoprim | 1977 |
A new experimental model of hyperphenylalaninemia in rat. Effect of p-chlorophenylalanine and cotrimoxazole.
Topics: Animals; Disease Models, Animal; Drug Combinations; Fenclonine; Humans; Kidney; Liver; Male; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias; Rats; Sulfamethoxazole; Trimethoprim; Tyrosine | 1977 |
Myelin deficiency in experimental phenylketonuria: contribution of the aromatic acid metabolites of phenylalanine.
Topics: Animals; Brain; Disease Models, Animal; Female; Fenclonine; Humans; Male; Membrane Lipids; Myelin Proteins; Myelin Sheath; Phenylacetates; Phenylalanine; Phenylketonurias; Phenylpyruvic Acids; Rats | 1978 |
Experimental phenylketonuria: metabolic studies in rat liver.
Topics: Animals; Disease Models, Animal; Fasting; Female; Fenclonine; Fructosephosphates; Gluconeogenesis; Glucose; Glucosephosphates; Humans; Hydroxybutyrate Dehydrogenase; Ketone Bodies; L-Lactate Dehydrogenase; Liver; Malate Dehydrogenase; NAD; Phenylalanine; Phenylketonurias; Rats; Stereoisomerism | 1977 |
Amino acid metabolism in the chronically uremic rat.
Topics: Amine Oxidase (Copper-Containing); Amines; Amino Acids; Animals; Argininosuccinate Lyase; Argininosuccinate Synthase; Brain; Chronic Disease; Citrulline; Dietary Proteins; Disease Models, Animal; Hydroxyindoleacetic Acid; Kidney; Liver; Monoamine Oxidase; Multienzyme Complexes; Muscles; Myocardium; Ornithine Carbamoyltransferase; Phenylalanine; Phenylalanine Hydroxylase; Rats; Tryptophan; Tryptophan Oxygenase; Tyrosine Transaminase; Uremia | 1975 |
[Phenylalanine-influenced retinal changes in the newborn rat (author's transl)].
Topics: Animals; Animals, Newborn; Disease Models, Animal; Ganglia; Humans; Phenylalanine; Phenylketonurias; Rats; Retina; Retinal Diseases | 1977 |
Influences of exogenous intake and nitrogen balance on plasma and brain aromatic amino acid concentrations.
Topics: Amino Acids; Animals; Disease Models, Animal; Female; Liver Diseases; Nitrogen; Octopamine; Parenteral Nutrition; Phenylalanine; Portacaval Shunt, Surgical; Rats; Tryptophan; Tyrosine | 1978 |
Phenylalanine depletion for the management of phenylketonuria: use of enzyme reactors with immobilized enzymes.
Topics: Ammonia-Lyases; Animals; Disease Models, Animal; Dogs; Enzymes, Immobilized; Extracorporeal Circulation; Humans; Phenylalanine; Phenylalanine Ammonia-Lyase; Phenylketonurias | 1978 |
Beneficial effect of isoleucine on fetal brain development in induced phenylketonuria.
Topics: Amino Acids; Animals; Body Weight; Brain; Disease Models, Animal; Female; Humans; Isoleucine; Organ Size; Phenylalanine; Phenylketonurias; Pregnancy; Rats | 1978 |
[Comparative effects of different inhibitors of phenylalanine hydroxylase and dihydropteridine reductase. In vivo and in vitro study in rats].
Topics: Animals; Dihydropteridine Reductase; Disease Models, Animal; Humans; Liver; NADH, NADPH Oxidoreductases; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias; Rats; Tyrosine | 1978 |
Experimental phenylketonuria: replacement of carboxyl terminal tyrosine by phenylalanine in infant rat brain tubulin.
Topics: Amino Acid Sequence; Animals; Brain; Cytoplasm; Disease Models, Animal; Humans; Microtubules; Phenylalanine; Phenylketonurias; Protein Binding; Rats; Tubulin; Tyrosine | 1979 |
Alpha-methylphenylalanine, a new inducer of chronic hyperphenylalaninemia in sucling rats.
Topics: Amino Acids; Animals; Animals, Newborn; Disease Models, Animal; Humans; Liver; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias; Rats | 1976 |
Regional brain indoleamine metabolism following chronic portacaval anastomosis in the rat.
Topics: Animals; Brain; Disease Models, Animal; Fatty Acids; Histidine; Hydroxyindoleacetic Acid; Hypothalamus; Isoleucine; Leucine; Liver Cirrhosis; Phenylalanine; Portacaval Shunt, Surgical; Rats; Serotonin; Tryptophan; Tyrosine; Valine | 1976 |
Hyperphenylalaninaemia and experimental allergic encephalomyelitis.
Topics: Animals; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Fatty Acids, Unsaturated; Female; Male; Multiple Sclerosis; Myelin Sheath; Phenylalanine; Rats | 1976 |
Maternal hyperphenylalaninemia: an experimental model in rats.
Topics: Animals; Animals, Newborn; Birth Weight; Brain Chemistry; Disease Models, Animal; Female; Fetal Blood; Humans; Maternal-Fetal Exchange; Phenylalanine; Phenylketonurias; Placenta; Pregnancy; Pregnancy Complications; Rats; Rats, Inbred F344; Time Factors | 1976 |
Reduced central serotonergic activity in mania: implications for the relationship between depression and mania.
Topics: Bipolar Disorder; Brain; Depression; Disease Models, Animal; Humans; Hydroxyindoleacetic Acid; Hypnotics and Sedatives; Imipramine; Lithium; Methysergide; Monoamine Oxidase Inhibitors; Phenylalanine; Probenecid; Serotonin; Tryptophan | 1975 |
Effects of anoxia and ischemia on protein synthesis in perfused rat hearts.
Topics: Aerobiosis; Anaerobiosis; Animals; Coronary Circulation; Coronary Disease; Disease Models, Animal; Hypoxia; Lactates; Male; Muscle Proteins; Myocardium; Perfusion; Phenylalanine; Phosphocreatine; Purine Nucleotides; Rats | 1976 |
A finding of highly selective synthetic inhibitor of plasma kallikrein; its action to bradykinin generation, intrinsic coagulation and experimental DIC.
Topics: Animals; Blood Coagulation; Bradykinin; Disease Models, Animal; Disseminated Intravascular Coagulation; Endotoxins; Fibrinogen; Humans; In Vitro Techniques; Kallikreins; Kaolin; Kinetics; Mice; Partial Thromboplastin Time; Phenylalanine; Rats; Tranexamic Acid | 1992 |
Boron neutron capture therapy of anterior chamber melanoma with p-boronophenylalanine.
Topics: Administration, Oral; Animals; Anterior Chamber; Autoradiography; Boron; Boron Compounds; Disease Models, Animal; Eye Neoplasms; Isotopes; Melanoma, Experimental; Neutrons; Phenylalanine; Rabbits; Radiation-Sensitizing Agents | 1992 |
[The activity of NADP-dependent dehydrogenases in the brain of growing animals with demyelinating exposures].
Topics: Animals; Brain; Chronic Disease; Cytoplasm; Demyelinating Diseases; Disease Models, Animal; Growth; Hypervitaminosis A; NADPH Dehydrogenase; Phenylalanine; Rats | 1991 |
[The characteristics of the brain cerebrosides, sulfocerebrosides and gangliosides in experimental demyelination and cerebrolysin administration].
Topics: Amino Acids; Animals; Brain; Brain Chemistry; Cerebrosides; Chronic Disease; Demyelinating Diseases; Disease Models, Animal; Gangliosides; Phenylalanine; Rats | 1991 |
[The effect of cerebrolysin on the metabolism of brain phospholipids in growing animals with experimental demyelination].
Topics: Amino Acids; Animals; Brain; Brain Chemistry; Chromatography, Thin Layer; Demyelinating Diseases; Disease Models, Animal; Growth; Phenylalanine; Phospholipids; Rats | 1991 |
In situ detection of cutaneous melanoma by prompt gamma-ray spectrometry using melanoma-seeking 10B-dopa analogue.
Topics: Aged; Animals; Boron; Boron Compounds; Cricetinae; Disease Models, Animal; Female; Humans; Isotopes; Male; Melanoma; Mesocricetus; Phenylalanine; Skin Neoplasms; Spectrometry, Gamma; Time Factors | 1990 |
The use of N-ethyl-N-nitrosourea to produce mouse models for human phenylketonuria and hyperphenylalaninemia.
Topics: Amino Acid Metabolism, Inborn Errors; Animals; Crosses, Genetic; Disease Models, Animal; Ethylnitrosourea; Female; Humans; Male; Mice; Mice, Mutant Strains; Mutation; Phenotype; Phenylalanine; Phenylketonurias | 1990 |
Evidence for inhibition of exodus of small neutral amino acids from non-brain tissues in hyperphenylalaninaemic rats.
Topics: Amino Acids; Animals; Biological Transport; Brain; Disease Models, Animal; Liver; Male; Muscles; Phenylalanine; Phenylketonurias; Rats; Rats, Inbred Strains | 1989 |
Effects of phenylalanine loading on protein synthesis in the fetal heart and brain of rat: an experimental approach to maternal phenylketonuria.
Topics: Animals; Brain; Carbon Radioisotopes; Disease Models, Animal; Female; Fenclonine; Fetal Heart; Fetus; Leucine; Maternal-Fetal Exchange; Phenylalanine; Phenylketonurias; Polyribosomes; Pregnancy; Protein Biosynthesis; Rats; Rats, Inbred Strains; Urea | 1986 |
Studies on experimentally induced hyperphenylalaninemia.
Topics: Animals; Disease Models, Animal; Drug Combinations; Female; Fenclonine; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias; Rats; Rats, Inbred Strains; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
A model for hyperphenylalaninaemia due to tetrahydrobiopterin deficiency.
Topics: Animals; Biopterins; Brain; Catecholamines; Disease Models, Animal; Dose-Response Relationship, Drug; Hypoxanthines; Liver; Mice; Mice, Inbred BALB C; Phenylalanine; Pteridines | 1986 |
Hyperphenylalaninemia in the hph-1 mouse mutant.
Topics: Aminohydrolases; Animals; Biopterins; Disease Models, Animal; GTP Cyclohydrolase; Half-Life; Male; Metabolic Clearance Rate; Mice; Mice, Mutant Strains; Phenylalanine; Tyrosine | 1988 |
Outcome of pregnancy in the rat with mild hyperphenylalaninaemia and hypertyrosinaemia: implications for the management of "human maternal PKU".
Topics: Animals; Brain Diseases; Discrimination, Psychological; Disease Models, Animal; Female; Motor Activity; Phenylalanine; Phenylketonurias; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Rats; Space Perception; Tyrosine | 1985 |
Biological and behavioural assessments of young rhesus monkeys after intrauterine exposure to high phenylalanine concentrations.
Topics: Animals; Disease Models, Animal; Female; Learning; Macaca mulatta; Phenylalanine; Phenylketonurias; Pregnancy; Pregnancy Complications | 1985 |
The use of animal models for the study of aminoacidopathies.
Topics: Age Factors; Amino Acid Metabolism, Inborn Errors; Animals; Brain; Brain Damage, Chronic; Cricetinae; Disease Models, Animal; Enzyme Precursors; Haplorhini; In Vitro Techniques; Nerve Tissue Proteins; Phenylalanine; Phenylalanine Hydroxylase; Phenylpyruvic Acids; Rats | 1972 |
Hepatic and renal protein synthesis in normal, diabetic and ketotic Chinese hamsters.
Topics: Amino Acids; Animals; Carbon Radioisotopes; Cricetinae; Diabetes Mellitus; Diabetic Ketoacidosis; Disease Models, Animal; In Vitro Techniques; Kidney; Liver; Phenylalanine; Proteins; Ribosomes | 1974 |
Enduring behavioral changes in rats with experimental phenylketonuria.
Topics: Aggression; Animals; Appetitive Behavior; Avoidance Learning; Behavior, Animal; Brain; Defecation; Disease Models, Animal; Female; Fenclonine; Humans; Liver; Male; Motor Activity; Organ Size; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias; Rats; Rats, Inbred Strains | 1972 |
On the mechanism of fever caused by the mucopeptide of group A streptococcus.
Topics: Animals; Bacterial Proteins; Brain; Disease Models, Animal; Fenclonine; Fever; Injections, Intravenous; Injections, Spinal; Mucoproteins; Norepinephrine; Phenylalanine; Premedication; Rabbits; Reserpine; Serotonin; Streptococcus; Streptococcus pyogenes; Tyrosine | 1972 |
Cataractogenesis in infant rats with model phenylketonuria.
Topics: Age Factors; Animals; Animals, Newborn; Cataract; Disease Models, Animal; Female; Fenclonine; Humans; Light; Liver; Male; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias; Rats; Rats, Inbred Strains | 1972 |
Behavioral effects of experimental maternal hyperphenylalaninemia.
Topics: Animals; Animals, Newborn; Avoidance Learning; Behavior, Animal; Disease Models, Animal; Exploratory Behavior; Female; Fenclonine; Fetus; Gestational Age; Humans; Maternal-Fetal Exchange; Motor Activity; Phenylalanine; Phenylketonurias; Pregnancy; Rats; Reinforcement Schedule; Social Behavior | 1973 |
Experimental maternal hyperphenylalaninemia: biochemical effects and offspring development.
Topics: Aggression; Animals; Animals, Newborn; Body Weight; Brain; Brain Chemistry; Disease Models, Animal; Embryonic and Fetal Development; Female; Fenclonine; Growth; Humans; Maternal Behavior; Maternal-Fetal Exchange; Organ Size; Phenylalanine; Phenylketonurias; Pregnancy; Rats | 1974 |
Control of liver and brain aromatic amino-acid metabolism by phenylalanine hydroxylase.
Topics: Animals; Brain; Brain Chemistry; Chemical Phenomena; Chemistry; Disease Models, Animal; Electrophoresis, Polyacrylamide Gel; Enzyme Induction; Enzyme Inhibitors; Fenclonine; Guinea Pigs; Humans; Kinetics; Liver; Mice; Molecular Biology; Mutation; Organ Culture Techniques; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias; Rats; Temperature | 1973 |
Chronic viral neuropathies: models for study and food for thought.
Topics: Animals; Antiviral Agents; Cattle; Chick Embryo; Cricetinae; Cytarabine; Cytomegalovirus; Dactinomycin; Deoxyuridine; Disease Models, Animal; DNA, Viral; Encephalitis Viruses; Friend murine leukemia virus; Humans; Imidazoles; Interferons; Mice; Mitomycins; Nervous System Diseases; Parainfluenza Virus 1, Human; Phenylalanine; Prions; Respirovirus; RNA Viruses; RNA, Viral; Vesicular stomatitis Indiana virus; Viral Interference; Virus Diseases | 1969 |
Experimental disciform serous retinal detachment. II. Autoradiography of photoreceptor protein metabolism.
Topics: Animals; Autoradiography; Disease Models, Animal; Eye Proteins; Female; Hyaluronoglucosaminidase; Leucine; Male; Microbial Collagenase; Phenylalanine; Photoreceptor Cells; Rabbits; Retinal Detachment; Time Factors; Tritium | 1974 |
Recovery of rat brain from a brief hyperphenylalaninemic insult early in development.
Topics: Age Factors; Animals; Body Weight; Brain; Disease Models, Animal; DNA; Growth Disorders; Humans; Lipid Metabolism; Nerve Tissue Proteins; Organ Size; Phenylalanine; Phenylketonurias; Rats; Rats, Inbred Strains; RNA | 1974 |
The enduring behavioral changes in rats with experimental phenylketonuria.
Topics: Age Factors; Animals; Avoidance Learning; Behavior, Animal; Brain; Cataract; Cerebellum; Conditioning, Operant; Disease Models, Animal; Female; Humans; Learning Disabilities; Male; Motor Activity; Myelin Sheath; Organ Size; Phenylalanine; Phenylketonurias; Rats; Time Factors | 1974 |
Some observations on the blood levels of phenylalanine in dilute mice and a comparison between human phenylketonuria and the disease of mice homozygous for the dilute lethal gene.
Topics: Age Factors; Animals; Chromosome Aberrations; Chromosome Disorders; Disease Models, Animal; Drug Tolerance; Female; Genes, Lethal; Homozygote; Humans; Male; Metabolic Clearance Rate; Mice; Phenylalanine; Phenylketonurias; Sex Factors; Time Factors | 1972 |
Neuronal lesions in the cerebellum following the administration of excess phenylalanine to neonatal rats.
Topics: Animals; Animals, Newborn; Axons; Cerebellum; Cytoplasm; Cytoplasmic Granules; Disease Models, Animal; Female; Humans; Liver; Myelin Sheath; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias; Purkinje Cells; Rats; Tyrosine | 1973 |
Vitamin A deficiency-induced "rod thinning" to permanently decrease the production of rod outer segment material.
Topics: Animals; Autoradiography; Diet; Disease Models, Animal; Electroretinography; Epithelium; Eye Proteins; Follow-Up Studies; Isoleucine; Phenylalanine; Photoreceptor Cells; Rats; Retina; Retinal Diseases; Tritium; Vitamin A; Vitamin A Deficiency | 1974 |
Retinal dystrophy in the pigmented rat.
Topics: Animals; Autoradiography; Disease Models, Animal; Epithelium; Fundus Oculi; Humans; Leucine; Ophthalmoscopy; Phagocytosis; Phenylalanine; Photoreceptor Cells; Rats; Rats, Inbred Strains; Retinal Degeneration; Retinitis Pigmentosa; Time Factors; Tritium | 1974 |
[Experimental hyperphenylalanaemic animals and cystathionine contents in brain tissues].
Topics: Amino Acid Metabolism, Inborn Errors; Amino Acids; Animals; Brain; Brain Chemistry; Diet; Dipeptides; Disease Models, Animal; Haplorhini; Hydro-Lyases; L-Serine Dehydratase; Male; Metabolic Diseases; Mixed Function Oxygenases; Phenylacetates; Phenylalanine; Phenylpyruvic Acids; Rats; Swine; Tyrosine | 1970 |
Differential reinforcement of latency (DRL) in phenylketonuric monkeys.
Topics: Animals; Conditioning, Operant; Diet; Disease Models, Animal; Feeding Behavior; Female; Frustration; Haplorhini; Humans; Macaca; Phenylalanine; Phenylketonurias; Pregnancy; Reaction Time; Reinforcement, Psychology; Reward | 1970 |
L-benzylalanine as a model amino acid for the study of accumulation diseases.
Topics: Amino Acids; Animals; Brain; Disease Models, Animal; Humans; Male; Phenylalanine; Phenylbutyrates; Phenylketonurias; Rats | 1971 |
Degenerative changes of neurocytes in the light of autoradiographic investigations.
Topics: Adenine; Amino Acids; Animals; Autoradiography; Brain; Carbon Isotopes; Cerebral Cortex; Disease Models, Animal; Female; Glycine; Leucine; Male; Nerve Degeneration; Nerve Tissue Proteins; Nervous System Diseases; Neurons; Nucleoproteins; Phenylalanine; Radiation Injuries, Experimental; Rats; Rats, Inbred Strains; Sciatic Nerve; Thymidine; Tritium | 1971 |
[Behavior of serum amino acids in rats with experimentally produced hyperphenylalaninemia].
Topics: Alanine; Amino Acids; Animals; Disease Models, Animal; Glutamates; Phenylalanine; Proline; Rats; Threonine | 1971 |
Alterations of individual free amino acids in brain during acute hepatic coma.
Topics: Amino Acids; Animals; Brain Chemistry; Cerebral Cortex; Disease Models, Animal; Dogs; Hepatic Encephalopathy; Histidine; Liver; Models, Biological; Nitrogen; Phenylalanine; Tryptophan; Tyrosine; Water | 1970 |
Hyperphenylalaninemia: disaggregation of brain polyribosomes in young rats.
Topics: Aging; Animals; Animals, Newborn; Brain Chemistry; Cell-Free System; Centrifugation, Density Gradient; Disease Models, Animal; Humans; Injections, Intraperitoneal; Phenylalanine; Phenylketonurias; Protein Biosynthesis; Rats; Ribosomes | 1970 |
Use of p-chlorophenylalanine to induce a phenylketonuric-like condition in rats.
Topics: Animals; Body Weight; Brain; Disease Models, Animal; Female; Humans; Intellectual Disability; Learning; Mixed Function Oxygenases; Norepinephrine; Phenylalanine; Phenylketonurias; Pregnancy; Rats; Serotonin; Swimming | 1970 |
Metabolism of phenylalanine in mice homozygous for the gene 'dilute lethal'.
Topics: Animals; Disease Models, Animal; Female; Genes, Lethal; Homozygote; Humans; Liver; Male; Mice; Mixed Function Oxygenases; Nervous System Diseases; Organ Size; Phenylalanine; Phenylketonurias; Phenylpyruvic Acids | 1970 |
Cerebral lipid metabolism in experimental hyperphenylalaninaemia: incorporation of 14C-labelled glucose into total lipids.
Topics: Animals; Animals, Newborn; Brain; Carbon Isotopes; Disease Models, Animal; Glucose; Humans; In Vitro Techniques; Lipids; Phenylacetates; Phenylalanine; Phenylketonurias; Phenylpyruvic Acids; Rats; Tyrosine | 1970 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |